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 Environmental tobacco smoke (ETS) exposure and poor dietary intake and quality 
are known to increase chronic disease risk in adults.  Chronic diseases like heart disease, 
diabetes, and metabolic syndrome (MetS) are major public health problems in the United 
States.  Adolescence is a time period of development of identity and autonomy and 
increasing importance of peer influence, making teens susceptible to substance abuse and 
poor dietary intake.  The relationships between ETS exposure, dietary intake and quality, 
nutrient biomarkers, and chronic disease have not been studied together in the adolescent 
population.  
 This project utilized data collected as a part of the 2001-2006 National Health and 
Nutrition Examination Survey (NHANES) – a nationally representative surveillance 
survey conducted in the United States.  Analyses were restricted to non-smokers.  
General linear models (GLM) were run in STATA to test for differences in diet 
quality/intake by ETS exposure and to determine whether ETS is related to measures of 
chronic disease risk in adolescents.  Subsequent analyses utilized the Sobel test to 
determine whether the relationship between ETS exposure and chronic disease risk was 
mediated by nutrient biomarkers.  GLMs with interaction terms were utilized to 
determine whether dietary intake/quality interacts with ETS exposure in the relationship 
with chronic disease risk.   
 These studies found that ETS-exposed adolescents had lower diet quality scores, 
higher saturated fat intake, and lower nutrient intakes than their unexposed peers.  ETS 
exposure was found to be positively correlated with continuous MetS score.  Mediation 




relationship between ETS exposure and MetS risk.  No interaction was identified 
between dietary intake and ETS exposure in the relationship with chronic disease risk.  
This research has demonstrated that adolescents who are exposed to ETS are more 
likely to have poor diet quality – both of which increase risk for chronic disease.  
Findings from this study also demonstrate the negative impact ETS exposure has on 
chronic disease risk and illustrate some of the potential mechanisms for this relationship.  
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There has been a dramatic reduction in smoking prevalence over the past few 
decades which has corresponded with scientific advances in knowledge and policy 
changes, but smoking is still a significant health problem in the United States.  Aside 
from the well-known relationships with lung cancer and asthma, tobacco smoke 
contributes to many negative health outcomes including heart disease, diabetes, and 
metabolic syndrome.  Research has shown that these health impacts are not limited to 
those who smoke, but also impact non-smokers who are exposed to environmental 
tobacco smoke (ETS).  Children and adolescents are particularly vulnerable to the effects 
of ETS exposure.  These same chronic diseases are known to be impacted by diet intake, 
dietary quality, and nutrient biomarkers.  Recommendations have been put forth for 
dietary intake in order to reduce risk of chronic diseases.   
Several studies have demonstrated relationships between smoking or exposure to 
ETS and poorer diet quality; however, the majority of these studies were conducted in 
adults and from over 10 years ago.  No recent studies have examined the differences in 
dietary intake and quality between ETS-exposed and unexposed adolescents.  While 
evidence suggests that ETS exposure may negatively impact chronic disease risk, this has 
not been systematically evaluated in adolescents, and though the mechanisms by which 
ETS and diet impact chronic diseases have some overlap, these relationships have not 
been thoroughly explored.  Due to these similarities in the pathways to development of 
chronic disease for ETS and diet, it is also possible that changes in diet could affect this 




The goal of this study is to understand how ETS exposure, diet, and chronic 
disease risk are related and the mechanisms behind these relationships.  This dissertation 
is comprised of several chapters.  Chapter 2 includes a background and rationale, 
including a conceptual model, outlining the larger picture of the public health problems 
and what is known about the relationship between smoking, ETS exposure, diet quality, 
nutrient biomarkers, and chronic disease; a description of the research aims; details about 
the data source and variables; and details about the analytic methods.   
Chapters 3 through 5 are manuscripts which describe the analyses conducted for 
the dissertation.  Chapter 3 examines the relationship between ETS exposure and dietary 
intake and quality amongst adolescents.  Specifically, this chapter aims to test the 
hypothesis that adolescents who are exposed to ETS have poorer diet quality as indicated 
by lower intake of micronutrients and higher intake of saturated fat.  While other studies 
have examined these relationships in adults, there is a paucity of information on this topic 
specific to adolescents.  It is important to understand whether or not poor diet quality and 
ETS exposure coexist as this would identify a segment of the population with multiple 
risk factors for chronic disease. 
Biomarkers of nutrient status are examined as a potential mediator in the 
relationship between ETS exposure and chronic disease risk in Chapter 4.  First, 
examining how ETS relates to chronic disease risk in adolescents is an under-studied 
topic that warrants further investigation.  Understanding the mechanisms by which ETS 
exposure impacts chronic disease risk is also of utmost importance as any identified 




In situations where ETS exposure cannot be eliminated, if differences in dietary 
intake are associated with reduced risk of chronic disease, this would suggest that 
improvements in diet intake and quality could mitigate the harmful effects of ETS 
exposure.  These relationships are evaluated in Chapter 5. 
Chapter 6 is a concluding chapter with an overall summary of the findings, 







Tobacco smoking has been a public health concern for centuries.  Amongst males 
born in the United States from 1931 to 1940, at its peak, smoking prevalence was 62 percent 
and amongst females born during the same time period, the peak prevalence was 45 percent 
(1).  In the 1930’s and 1940’s most physicians smoked (2).  In fact, tobacco agencies utilized 
physicians in their advertisements with slogans such as, “More doctors smoke Camels than 
any other cigarette” and “Fredric March says…THIS IS IT ‘F&M FILTERS ARE JUST 
WHAT THE DOCTOR ORDERED!’” (2).  Much progress has been made with respect to 
smoking since these advertisements were made, and the prevalence of smoking has gone 
down significantly since its peak (see Figure 2.1.).  Amongst adults, the prevalence of 
smoking decreased from over 40 percent in 1965 to just under 25 percent in 1997 (3).  In the 
few years preceding 2011 and 2012, smoking prevalence amongst adults was 28 percent (4).  
Then, in 2011 and 2012, the prevalence decreased to roughly 25 percent (4).  
What caused this reduction in tobacco smoking?  Though cigarettes were long 
thought to cause lung problems and some studies had provided evidence to that effect 
(documented as early as clinical observations published in 1795 (5)), the study which was 
considered groundbreaking was published in 1950 by Dr. Ernst L. Wynder and colleagues 
linking tobacco smoke to lung cancer in a study with over 680 cases of lung cancer (6).  It 
wasn’t until 14 years later in 1964 that the Surgeon General released a report which 
concluded, based on findings from over 7,000 articles, that tobacco smoking was associated 
with lung cancer and chronic bronchitis in men and women (3).  Subsequent to the Surgeon 
General’s report, in 1968 it was determined that the Fairness Doctrine applied to tobacco, 




to present the harmful effects of smoking and/or anti-smoking messages (3).  In 1971, 
tobacco products were banned from broadcast advertising altogether (3).  In the 1980’s, 
shortly after the first Great American Smokeout (a coordinated event where smokers are 
encouraged to set that date as the day they will quit), federal tobacco taxes were doubled.  
Other historical milestones include regulation and enforcement of laws restricting minors’ 
access to tobacco, restrictions on smoking in public spaces, and increases in prevention and 
treatment efforts (3).  Throughout this period of scientific discovery and regulatory changes, 
per capita cigarette consumption declined (see Figure 2.1).   
Figure 2.1. Per capita cigarette consumption and historical events from 1900-2012* 
 
*Figure from U.S. Department of Health and Human Services. The Health Consequences of  
Smoking — 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: U.S.: 




Since the discovery that tobacco smoke causes lung cancer, research has established 
causal relationships between smoking and a plethora of other diseases including: other forms 
of cancer (pancreatic, bladder, esophageal, throat, mouth, liver, colorectal, breast); multiple 
forms of heart disease (ischaemic, pulmonary, myocardial) and vascular diseases (cerebral, 
peripheral); hypertension; arteriosclerosis; and a multitude of lung/respiratory conditions 
(chronic bronchitis, Chronic Obstructive Pulmonary Disease (COPD), emphysema, asthma, 
pneumonia, tuberculosis); exposure during pregnancy and orofacial clefts; ectopic 
pregnancy; erectile dysfunction; macular degeneration; diabetes; suppression of the immune 
system; rheumatoid arthritis; mortality; and poorer general health (5, 7).   
Environmental Tobacco Smoke (ETS) exposure, sometimes referred to as secondhand 
smoke, is the involuntary inhalation of a combination of exhaled mainstream smoke, and side 
stream smoke, the non-inhaled smoke produced from burning tobacco (7).  ETS exposure can 
be assessed in multiple ways including subjective measurements, like self-report, and more 
objective measures like cotinine (a byproduct of nicotine metabolism) concentration and 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanol (or NNAL) (a byproduct of tobacco specific 
nitrosamines) concentration from a urine, saliva, or blood sample.  Before ETS was formally 
acknowledged as a health risk by the Surgeon General, a non-smokers’ rights movement 
began in the 1970’s (3).  Then, 22 years after the first Surgeon General’s report to 
acknowledge the negative health effects of smoking, the Surgeon General released a report 
about the harmful effects of ETS.  The 1986 Surgeon General’s report on Involuntary 
Smoking concluded that ETS is a known human carcinogen and highlighted the following 
health effects of ETS exposure: lung cancer; increased risk of infection, respiratory illnesses 




function in children and adults (8).  The report also indicated that additional research was 
necessary to determine whether or not ETS increases risk of other cancers and cardiovascular 
diseases (8).   
 Research continued to demonstrate harmful effects of ETS, and 20 years after the first 
Surgeon General Report about ETS exposure, another report was published.  The 2006 
Surgeon General Report concluded that the health effects of ETS extend beyond the 1986 
report to include the following: mortality; increased risk of Sudden Infant Death Syndrome 
(SIDS); slowed lung growth in children; coronary heart disease in adults (9).  The report also 
found evidence of possible relationships between ETS exposure and preterm delivery, low 
birth weight, childhood cancer, breast cancer, other cancers, stroke, Chronic Obstructive 
Pulmonary Disease (COPD) (9).  In fact, a meta-analysis conducted for the report indicated a 
25-30 percent elevated risk of coronary heart disease due to ETS exposure (9). 
While smoking has declined, it has not been eradicated in the United States.  Because 
smoking is still a public health problem, many individuals are also at risk of ETS exposure.  
Some of the regulatory efforts which have aimed to reduce ETS exposure include indoor 
smoking bans, prohibition of smoking on airplanes, and workplace smoking restrictions (3).  
ETS exposure as defined by cotinine concentration between 0.05 and 10 ng/mL was over 50 
percent from 1999-2000, was between 37 and 47 percent between 1999 and 2006, and has 
decreased by almost half to just over 25 percent in 2012; however, 58 million individuals 
were still exposed in 2011-2012 (10, 11).  There are disparities in ETS exposure with 
children having higher rates of exposure than adults (10).  




Despite regulations to decrease smoking in general and efforts to specifically reduce 
advertising targeting adolescents (3), smoking is still a problem amongst adolescents in the 
United States.  From 2005 to 2013, the smoking prevalence amongst high school students 
decreased an average of 4.2 percent per year, leading to a prevalence of 15.7 percent (4).  
While this trend is in the right direction for improvements in public health, the percentage of 
adolescents who have ever tried a tobacco product is still alarmingly high.  In 2013, 46 
percent of high school students had tried any tobacco product.  In 2014, over 4.5 million 
middle and high school students were estimated to be currently using any tobacco product 
(12).  Tobacco is likely to remain a public health issue for years to come as the tobacco 
industry is constantly evolving and developing new products, posing new challenges to 
tobacco regulation and smoking prevention and cessation efforts.  For example, the most 
commonly used tobacco product amongst adolescents is now e-cigarettes (12). 
 ETS exposure is also a public health problem amongst United States adolescents.   
As mentioned earlier, adolescents have higher prevalence of ETS exposure than adults (10).  
Max et. al. examined NHANES data from 1999-2006 to determine rates of exposure to 
secondhand smoke.  As reported earlier, ETS exposure as assessed by cotinine concentration 
was between 37 and 47 percent prevalent amongst adults between 1999 and 2006.  However, 
to give a sense of the difference in exposure between adults and adolescents, during the same 
time period, adolescent exposure was estimated to be between 47 and 63 percent (11).   
 What are the sources of ETS exposure in the adolescent population?  Parental and 
close friend smoking status and perception that ETS exposure is harmful were both found in 
international studies to be determinants of ETS exposure in adolescents (13-16).  




In a study conducted in a country with high rates of smoking and high rates of ETS exposure, 
authors found that cotinine concentration was highest on Mondays and postulated that this 
was due to children being around their smoking parents more on the weekends than 
weekdays (16).  The 2006 Surgeon General’s Report on Involuntary Exposure to Smoking 
indicated that people spend the majority of their time at home, so for those living with a 
smoker, this is likely the most critical location with respect to exposure (9).  Other potential 
sites for exposure in children include public places, restaurants, and schools.   
 There are biological reasons why ETS exposure may be more harmful in adolescents 
than in adults.  ETS is metabolized differently in adolescents than in adults.  In a study 
examining NHANES data, the prevalence of ETS exposure in children was higher than adults 
based on self-report and cotinine concentration.  Children (3-11 years) had mean cotinine 
concentrations ranging from 0.11-0.18 ng/mL compared to 0.09-0.14 ng/mL in adolescents 
(12-19) and 0.06-0.08 ng/mL in adults (20 and older) (11).  In a research study examining the 
concentrations of cotinine and NNAL and other tobacco-related carcinogens amongst non-
smokers in the United States using NHANES data, urinary NNAL was detected in 41% of 
non-smokers.  Authors noted that adolescents aged 12 to 19 years had twice the NNAL as 
adults (and children aged 6 to 11 had four times as much as adults) (17).    Some explanations 
for the higher concentrations of cotinine and NNAL measured in non-smokers under the age 
of 19 years as compared with their adult counterparts include smaller size, different 
respiration, inability to escape exposure, and time spent in the home (17).  Willers et al. 
conducted a semi experimental study on 14 children (aged 4-11 years) and 7 adults after 
exposure to the same amount of secondhand tobacco smoke (18).  Willers measured urinary 




children as compared to 13 mg/L in adults (p=0.005).  Willers explained that children have a 
higher ventilation rate per unit of body weight, causing them to have a higher dose of 
nicotine at the same concentration of exposure as adults (18).  Furthermore, Willers also 
suggested that differences may exist in metabolism between adults and children (18). 
There are several aspects of the adolescent life stage that make it an important time 
period for studying tobacco use and exposure.  Adolescence is a period of establishing 
identity and self-perception (19).  Identity is composed both of sense of self and continuity of 
oneself across this period of development but also one’s place within the context of larger 
groups and society as a whole (19).  Experimentation and autonomy from parents are key 
parts of establishment of identity (19, 20) which lend themselves to experimentation with 
tobacco. 
While parents and family continue to influence adolescents, relationships change and 
the influence of peers reaches its peak during adolescence (19, 21).  This process begins in 
early adolescence, and by late adolescence, the adolescent has developed a separate identity 
from his or her parents and peers (20).  The Theory of Triadic Influence asserts that both 
direct and interactive factors impact adolescent smoking (22, 23).  Three major categories of 
influence include intrapersonal, interpersonal, and attitudinal.  Both parent and friend 
smoking have been found to influence smoking acquisition and continuation of smoking into 
young adulthood (23).  Psychological factors found to influence smoking behavior in 
adolescents include having a desire not to be like one’s parents and to be like one’s peers 
(23).     
From a cognitive development standpoint, adolescence is a period transition from 




think about thinking (20).  The ability to think abstractly lays the framework for adolescents 
to eventually be able to process potential consequences of their actions as adults, but this new 
cognitive capability is in its infancy and, therefore, while adolescents may recognize a 
behavior as risky, they may not yet be able to fully comprehend the long-term effects (20).   
These characteristics of adolescence make it an important period of transition for the 
formation of health behaviors.  Will the adolescent identify herself as a member of a group 
who smokes?  Will that peer influence cause her to smoke?  Will she begin to integrate 
smoking into her identity?  Does the adolescent have the capacity to think abstractly enough 
to understand that if she smokes, she is putting her health at risk?  Can smoking be a form of 
establishing autonomy from one’s parents?    
 Cigarette smoking in children and adolescents is a great concern due to the addictive 
nature of cigarettes and the finding that children and adolescents who smoke are more likely 
to smoke as young adults and have greater risk of other negative health outcomes (23, 24).   
Health behaviors developed in adolescence track into adulthood.  This has been demonstrated 
specifically in longitudinal studies of smoking which have found that adolescents who smoke 
are more likely to smoke as young adults and adults than adolescents who do not smoke (25-
27). 
2.1.2. Chronic disease in the United States 
Cardiovascular disease (CVD) and diabetes (T2DM) are two of the leading causes of 
death in the U.S. causing 597,689 and 69,071 deaths in 2010 respectively (28, 29).  Data 
from the National Health Interview Survey in 2009 demonstrated that in a sample of 227,371 
adults, 11.8 percent had CVD, 24.9 percent had hypertension, 2.6 percent had experienced a 




Nutrition Examination Survey (2003-2006) indicated a 34 percent prevalence of metabolic 
syndrome (MetS) (a disease associated with increased risk for CVD and diabetes) (31). 
One major preventable contributor to chronic disease is tobacco.  From 2005-2009, 
397,840 males and 422,330 females ages 35 years and older died from cardiovascular and 
metabolic diseases (7).  Of those deaths, 95,600 and 65,000, respectively, could be attributed 
to smoking (7).  ETS alone accounts for approximately 41,280 deaths annually to non-
smokers due to heart disease and lung cancer (7). 
 Chronic disease develops across the lifespan.  The Developmental Origins of Health 
and Disease hypothesis argues that chronic disease development begins as early as the fetal 
environment – that adverse conditions in utero can negatively impact phenotype leading to 
increased susceptibility to chronic disease (32).  Precursors to cardiovascular disease such as 
increased local pulse-wave velocity, left ventricular mass, left atrial volume, and carotid 
intima-media thickness have been observed in obese adolescents (33, 34).     
Prevalence and characterization of chronic disease differs between pediatric and adult 
populations.  MetS is clearly defined in adults; however, it has been less clearly defined in 
children and adolescents.  Furthermore, the prevalence of MetS, like many other chronic 
diseases which may develop over an extended period of time, is lower in children and 
adolescents (35).  Therefore, it is especially important to use a continuous measure of MetS 
for children and adolescents when examining determinants of disease in order to have 
sufficient power to detect relationships.  Other arguments for a continuous score are that it is 
less susceptible to error than dichotomous characterization of MetS and it is a more sensitive 
measure (35).  In a pediatric population, the components of MetS must be age and gender 




plasma glucose as is done with adult populations, it is better to utilize homeostasis 
assessment model of insulin resistance (HOMA-IR) because most children have normal 
fasting plasma glucose (36).  HOMA-IR is an assessment of insulin sensitivity (22.5/[fasting 
insulin X fasting glucose]) (37).  Furthermore, in order to incorporate both systolic and 
diastolic blood pressure, mean arterial pressure (MAP = ((systolic blood pressure-diastolic 
blood pressure)/3)) + diastolic blood pressure)) is ideal for use in the calculation of a 
continuous MetS score for pediatric populations (36).   
The definitions of hypertension and dyslipidemia are different for adults and 
adolescents.  For adults, cutoff values are used to delineate absence of hypertension from 
prehypertension and hypertension.  For children, prehypertension, stage 1 hypertension, and 
stage 2 hypertension are based on blood pressure percentiles for age and sex (38).  While 
cutoffs are used for diagnosis of high cholesterol in children and adults, the cutoff values are 
different, and there is a “borderline hypercholesterolemia” category for children which does 
not exist for adults (39).  Finally, there is a Framingham CVD Risk Score that can be used in 
adults but not in children. 
CVD, T2DM, and MetS are also prevalent amongst adolescents in the United States.  
NHANES data from 2,456 adolescents aged 12 to 19 years demonstrated an 8.6 percent 
prevalence of MetS.  Approximately half of the sample had one of the criteria for the disease.  
In this sample, 6.9 percent had blood pressure greater than or equal to the 90th percentile and 
14 percent had fasting plasma glucose greater than or equal to 100 mg/dL (40).  Using 
NHANES data from 1999 through 2006, Ford et. al. found that 8.6 percent of adolescents 
aged 12-17 years had elevated total cholesterol using the National Cholesterol Education 




Many aspects of the relationship between ETS exposure and chronic disease risk have 
not been thoroughly evaluated.  The following sections of Chapter 2 provide the background 
behind some of those still unexplored relationships.  A visual depiction of these yet 
unexplored relationships – a conceptual model – is presented in Figure 2.2. 
Figure 2.2. Conceptual Model 
 
2.1.3. Mechanisms by which ETS impacts chronic disease risk 
ETS exposure is associated with the development of CVD in both adults and children 
(42).  The effects of ETS are a result of a combination of smoke components including 
carbon monoxide, nicotine, polycyclic aromatic hydrocarbons, and other elements.  In 
particular, exposure to ETS induces oxidative stress when carbon monoxide displaces and 
competes with oxygen for binding sites on red blood cells, which reduces the blood’s ability 
to deliver oxygen to the heart and compromises the myocardium’s ability to use oxygen to 
create adenosine triphosphate (43).  Other mechanisms that may also explain this relationship 
include effects on inflammation, platelet aggregation, and endothelial dysfunction (44).  And, 
with these mechanisms, research has found that ETS exposed individuals appear to have 
disproportionately increased concentrations of two biomarkers of CVD risk: fibrinogen and 
homocysteine (43, 45, 46).  In a cross-sectional study of 205 young adult females (18-22 
years old), investigators examined a host of lifestyle characteristics and their associations 




investigators found that exposure to ETS was statistically significantly associated with high 
intima media thickness – a known risk factor for CVD (OR: 1.5, p= 0.018) (47). 
ETS exposure also increases risk for T2DM and MetS.  A population-based cohort 
study examined the effect of passive and active smoking on T2DM incidence and found that 
among never smokers, subjects exposed to ETS had increased T2DM risk (48).  A growing 
body of evidence indicates that a possible biological explanation for this relationship is the 
positive association between ETS exposure and insulin resistance (49, 50).  With respect to 
risk for developing MetS, in a recent cross-sectional study, researchers found that exposure 
to ETS was independently and significantly associated with enhanced risks of MetS and its 
individual components (51).  
Adolescents exposed to ETS are also at higher risk for MetS.  Weitzman and 
colleagues examined the relationship between ETS exposure and MetS amongst 3,211 12-19 
year old adolescents in NHANES data from 1988 to 1994.  Using multivariable logistic 
regression including adjustment for age, race/ethnicity, gender, poverty, parent history, and 
region, ETS exposure was associated with a 4.7 fold increased risk of MetS (p=0.003) (50).  
This relationship remained in subsequent analyses examining only overweight and obese 
youth.  Authors argued that the established association between smoking and insulin 
resistance could explain these findings.    
It is evident that ETS is associated with reductions in concentrations of antioxidants 
in those who are exposed when compared to those who are unexposed (42, 52-57).  Also 
apparent is the relationship between low concentrations of antioxidants and increased risk of 
chronic disease (52, 54, 58, 59).  This supports the theory that nutrient biomarkers act as a 




reductions in antioxidants which, in turn, promotes the development of chronic disease.  
However, this mediating relationship has not been explored in the adolescent population.  
Specifically, ETS is associated with decreased concentrations of certain nutrient 
biomarkers including folate, ascorbic acid, β-cryptoxanthin, α-carotene, and β-carotene.  
ETS-exposed children have lower nutrient biomarker concentrations than unexposed children 
even after adjusting for dietary intake (52).  The evidence of the association between lower 
serum and red blood cell folate and ETS exposure stems from analysis of NHANES data in 
adults (n=15,564) (53), even after stratification by folate intake, 37 and in children (2,218 
children ages six to 18) (57). 
Several studies demonstrated negative associations between ETS exposure and 
ascorbic acid concentration.  Tribble et. al. recruited a sample of 141 premenopausal, healthy 
(no T2DM or CVD) women aged 25-45 years to examine the effects of smoking and ETS on 
plasma ascorbic acid.  Plasma ascorbic acid was statistically significantly lower in women 
who smoked or who were exposed to ETS than non-smoking women who were not exposed 
to ETS (55).  NHANES data has confirmed this association amongst children (n=2,968) aged 
four to 18 years.  Furthermore, Strauss et. al. reported a linear relationship between cotinine 
concentration and serum ascorbic acid and a dose-dependent relationship such that higher 
concentrations of ETS exposure were associated with lower concentrations of ascorbic acid 
(56).  Associations between ETS exposure and ascorbic acid concentrations often persist 
after adjustment for intake; however, most articles do not report whether intake differed 
between ETS exposed and unexposed groups (60). 
Carotenoid concentrations are also lower in the presence of ETS exposure.  In a study 




significantly lower in non-smoking women who lived with a smoker when compared to 
women who did not live with a smoker (60).  This relationship also exists in children and 
adolescents.  Investigators examined data from children enrolled in the Diabetes 
Autoimmunity Study in the Young (DAISY) (n=257) and discovered that ETS exposure was 
associated with lower β-cryptoxanthin, α-carotene, and β-carotene, regardless of intake (52).  
Analysis of NHANES data confirms this relationship in children and adolescents (n=2,218; 
ages 6-18 years) (57). 
2.1.4. Diet quality and chronic disease 
 Like ETS exposure, dietary intake is known to impact chronic disease development.  
As recognized by the Dietary Guidelines for Americans, produced by the United States 
Department of Agriculture and the Department of Health and Human Services as 
recommendations for dietary intake which will promote health and reduce the risk of chronic 
disease, decreased intakes of sodium, saturated fatty acids, solid fats, cholesterol, trans-fatty 
acids, added sugar, and alcohol and increased in intake of fruits, vegetables, whole grains, 
lean meats and protein sources, seafood, oils, milk, and milk products are associated with 
reduced risk of chronic disease (61).  Better scores on the alternate Healthy Eating Index 
(aHEI) are associated with lower concentrations of c-reactive protein (62, 63).    
Studies, including longitudinal cohort studies, investigating the aHEI have found that 
higher aHEI scores are associated with lower 10-year coronary heart disease risk, lower 
incidence of cardiovascular disease events and heart failure, and lower incidence of T2DM, 
and that the aHEI score was a stronger predictor of CVD risk than the HEI score (63-66).   
Evidence from randomized controlled trials has demonstrated that the DASH diet can 




high in fruits, vegetables, and low- or non-fat dairy, incorporates whole grains, includes 
beans, nuts, seeds, fish, and poultry, and vegetable oil, and restricts red meat, sweets, sodium, 
and sugar-sweetened beverages (67).  The goal for macronutrient composition is to have 
roughly 27 percent calories from fat, six percent from saturated fat, 55 percent from 
carbohydrates, and 18 percent from protein (67).  The diet aims to restrict cholesterol to 150 
mg, sodium to less than 2,300 (or in more restricted versions, 1,500) mg, and to include 
4,700 mg potassium, 500 mg magnesium, 1,250 calcium, and 30 grams of fiber (based on a 
2,000 kcal diet) (67).  In randomized controlled trials, the DASH diet, when compared to the 
control group, has found to be associated with higher HDL and reductions in weight, blood 
pressure, and triglycerides, fasting plasma glucose, and c-reactive protein, LDL, and 
apolipoprotein (68, 69).  Another experimental study found that in obese individuals, 
antioxidant capacity increased with the DASH diet, which could explain some of the 
reduction in chronic disease risk seen with this diet (70). 
Intake of specific types of fats, such as polyunsaturated fatty acids, very long chain n-
3 fatty acids (VLC n-3), and monounsaturated fatty acids, have been associated with multiple 
positive health effects such as decreases in triglycerides, LDL cholesterol, inflammation, 
blood pressure, and effects on membrane structure, coagulation, lipoprotein oxidation, 
fibrinolysis, endothelium, and blood clotting (71-73).  Other fats, such as hydrogenated fats, 
have negative health effects including increased c-reactive protein and decreased interleukin-
8, increased reactive oxygen species, tumor necrosis factor, and promotion of atherosclerosis 
and inflammation, along with adverse effects on endothelial function and plaque rupture (74-
76).  Higher fiber consumption is associated with lower concentrations of c-reactive protein 




Many of the biomarkers of CVD risk also increase the risk of morbidity in those with 
T2DM.  Homocysteine, in particular, is a biomarker with clearly established relationships 
with both CVD and T2DM.  Some examples of dietary characteristics associated with 
homocysteine include high protein/low carbohydrate diets, polyunsaturated fatty acid, 
micronutrient, and folate intake (78-88).   Insulin, glucose, and HbA1c are biomarkers of 
T2DM risk which are affected by ETS exposure and dietary intake.       
Evidence from the chronic disease literature suggests an overlap in the pathways 
through which dietary intake and ETS exposure affect health outcomes (43-46, 71-96).  In 
particular, dietary intake affects a number of the same biomarkers (or risk factors) of CVD as 
does ETS exposure.  Cardiovascular disease, diabetes, and metabolic syndrome have some 
shared biological etiologies, including inflammation, oxidative damage, and oxidative stress.  
As previously demonstrated, ETS increases oxidative stress and decreases concentrations of 
antioxidants in the blood whereas dietary intake can either increase antioxidant capacity or 
increase oxidative stress depending on dietary quality (i.e., micronutrient and fat content).   
Homocysteine contributes to chronic disease risk by promoting oxidative injuries to 
arteries, damaging vasculature, inhibiting anti-coagulants, and facilitating smooth muscle 
proliferation (97).  As mentioned before, ETS exposure is also associated with elevated 
homocysteine.  Diet affects homocysteine as well.  One nutrient that impacts homocysteine is 
folate/folic acid – insufficient folate/folic acid intake can cause elevated homocysteine 
concentrations (98). 
2.1.5. The adolescent period and diet 
The developmental characteristics of the adolescent life stage described earlier have 




autonomy and control over their food choices.  They are also influenced by peer food 
selections, and these factors may lead to poor choices.  Adolescents are at risk for nutritional 
deficiencies due to poor diet quality (fast food, sugar, and soft drink consumption and 
insufficient dairy and fruits and vegetables) (99).  Due to growth occurring during 
adolescence, demand for energy and nutrients is higher, especially amongst adolescent boys 
(99).  Vitamin requirements approximate adult needs with the exception of vitamin B6 and 
niacin which have greater requirements, and iron, calcium, and phosphorus (and magnesium 
for females) needs exceed adult requirements (99).   
Data from the National Health and Nutrition Examination Survey have been utilized 
to examine whether or not adolescents meet dietary recommendations.  Analysis of the 1999-
2002 data demonstrated that only nine percent of adolescents consumed five or more fruits or 
vegetables in a day (100).  In 2003-2004, only 6.2 percent of adolescents met 
recommendations for fruit intake and 5.8 percent met recommendations for vegetable intake 
(101).  There is evidence that fruit and vegetable consumption decreases during this life stage 
(102).  Studies that have examined trends in child and adolescent diet in the United States 
demonstrate that vegetable intake decreased from 1989 to 2010 and fruit intake had declined 
early during this time period but recently increased from the 2003-2006 period to 2009-2010 
(103).  Other similar studies have found no change in vegetable intake in recent years and 
that despite increases in fruit intake amongst children and adolescents, in 2009-2010, 
adolescents were still not meeting the Healthy People 2020 goals for fruit and vegetable 
consumption (104). 
The evidence and opinions regarding whether dietary patterns in adolescence track 




adulthood and that this means that dietary intervention during adolescence is critical.  
Consumption of fruits, vegetables, and sugary foods has been found to track from 
adolescence to young adulthood (105).  When analyzed as a proportion of total food intake, a 
longitudinal study found that fruit, vegetable, potato, cereal, bread, fish, meat, and 
alternatives tracked over a 20 year period but found that dairy and sugary food intake did not 
track over time (106).   
2.1.6. Nutrient biomarkers and chronic disease 
Reduced concentrations of nutrient biomarkers have been associated with chronic 
disease.  There is a biological basis for this relationship.  Some micronutrients (i.e., retinol, 
α-carotene, and β-carotene) are required for epithelial cell differentiation and cell signaling 
and communication.  Other micronutrients act as antioxidants which shield cell membranes 
from damaging effects of lipid peroxidation (52).  Micronutrients in the blood can reduce cell 
proliferation and protect against platelet adhesion (52).  Epithelial cell differentiation, cell 
signaling and communication, insulin production, oxidation, cell proliferation, and platelet 
adhesion are all processes which can affect risk of CVD, T2DM, and MetS (59).   
Roberts and Sindhu published a review of the relationship between oxidative stress 
and MetS (59).  The authors defined oxidative stress as an imbalance between reactive 
oxygen species and antioxidant capacity and described how the antioxidant capacity is 
composed of both endogenous and dietary antioxidants (i.e., vitamin C, E, β-carotene, and 
phytochemicals).  The literature demonstrates that oxidative stress is associated with insulin 
resistance, adiposity, total body fat, waist circumference, endothelial dysfunction, lipoprotein 
atherogenicity, and arterial blood pressure – all components of either CVD, T2DM, or MetS 




In studies comparing those with chronic diseases to those without, nutrient 
biomarkers, especially those of antioxidants, are often lower amongst individuals with the 
disease than those without the disease.  A study comparing vitamin C concentrations in 
patients with peripheral arterial disease (PAD), hypertension without PAD, and healthy 
individuals found that PAD patients had statistically significantly lower vitamin C 
concentrations than hypertensive and healthy individuals and that this group was the only 
group to have any subclinical vitamin C deficiency (14% of PAD patients) (54).  A study of 
NHANES participants found that participants with MetS had statistically significantly lower 
vitamin C and carotenoid concentrations than those without MetS (58).  MetS has been 
associated with lower serum vitamin C and α-tocopherol concentrations (59).  Evidence for 
the causal relationship between oxidative stress and chronic disease is not entirely based on 
observational studies.  In a randomized controlled trial, antioxidant supplementation 
administered to patients with essential hypertension resulted in improvement in flow-
mediated dilation of the brachial artery, reductions in arterial stiffness, and reductions in 
insulin resistance (59). 
2.1.7. Diet quality and nutrient biomarkers 
Dietary intake of micronutrients, including antioxidants, is associated with blood 
concentrations of antioxidants.  Higher intakes of vitamin D, retinol, α-carotene, β-carotene, 
β-cryptoxanthin, lutein and lycopene are associated with higher concentrations of plasma 25-
hydroxyvitamin D, plasma retinol, plasma α-carotene, plasma β-carotene, plasma β-
cryptoxanthin, plasma lutein and plasma lycopene, respectively, in children aged nine months 
to eight years (52).  Amongst over 500 two to 13 year olds in Puerto Rico, plasma ascorbic 




2.1.8. Diet quality and smoking/ETS 
There is evidence in the literature that smoking is related to poor diet quality amongst 
adults and adolescents (108-112).  Adult smokers have lower intakes of vitamin C, fiber, 
dairy, fruits and vegetables, more fast food, and overall poorer diet quality (111, 113).  
Adolescent smokers consume fewer fruits, vegetables, dairy, and grains and more soft drinks 
(109, 114).  Furthermore, in a study conducted amongst a diverse sample of 4,746 
adolescents in Minnesota from 1998-1999, authors found that adolescent smokers had lower 
intake of fiber, calcium, iron, zinc, vitamin A, vitamin C, and folate than non-smokers (109).   
Some studies have also found a correlation between ETS exposure and poor diet 
quality (115-121); however, this literature is sparse and from 13-27 years ago.  There is also 
some evidence to suggest that adults exposed to ETS have poorer diet quality than unexposed 
individuals (less fruits, vegetables, milk, lean meats, complex carbohydrates, and beans; 
more fried food, fat, and cholesterol; lower iron, β-carotene, and fiber) (39, 115-122).   
In 1989, using data from over 3,000 adult members of Kaiser Permanente who had a health 
checkup, Sidney et. al. found that nonsmokers exposed to ETS had statistically significantly 
lower intakes of carotene than nonsmokers who were unexposed to ETS (123).  Amongst 
nonsmokers, those who live with smokers have a less healthy dietary intake than nonsmokers 
who do not live with a smoker (124).  Household ETS exposure has been associated with 
lower micronutrient content in the diet, and worksite ETS exposure is associated with lower 
vitamin C, fruit, and vegetable intake than those who are not exposed to ETS (121). 
If, in fact, dietary intake can exacerbate the negative effects of ETS on chronic 
disease risk, then a tendency for ETS exposed individuals to have less healthy diets would 




special consideration for confounding when investigating the potential mediating effect of 
nutrient biomarkers in the relationship between ETS and chronic disease.   
2.1.9. Summary 
While smoking has declined in the United States, it has not been eliminated.  
Smoking contributes to several of the leading causes of death in the United States – 
specifically cardiovascular disease and diabetes.  Similarly, ETS exposure increases risk of 
chronic disease as well.  Adolescents are in a developmental stage where they have not yet 
fully developed the ability to think abstractly to comprehend long-term consequences of their 
actions and they are trying to establish autonomy from their parents.  This makes them 
susceptible to initiation of substance use.  Adolescents are also at risk of poor diet quality in 
the United States.   
As demonstrated above, the relationships between dietary intake and chronic disease 
risk, ETS and chronic disease risk, dietary intake and antioxidant concentrations, ETS and 
antioxidant concentrations, and antioxidant concentrations and chronic disease risk are all 
well established in the literature.  However, insufficient research has been conducted to 
examine the bigger picture of how these factors work together to influence development of 
chronic disease.  It is important to understand whether or not ETS exposed adolescents have 
poorer diet quality because if that is the case, this is a high risk group to target for prevention 
efforts.  This study will bridge this gap in the literature by evaluating whether such clustering 
of health exposures and behaviors exists amongst the U.S. adolescent population.  
Identifying the biological mechanisms by which exposures impact health is one of 
many critical factors for establishing causal relationships.  While evidence suggests that part 




concentrations, this has not been systematically explored.  This study began investigating this 
possibility and provides evidence for future, longitudinal studies to examine this relationship 
further. 
A recent review of literature suggested that diet may have a partial interaction with 
ETS exposure/smoking in the development of these diseases, but that further research is 
necessary to establish this relationship (125).  The need for an examination of these 
relationships within the same population at the same time is striking.  By assessing the 
influence of dietary characteristics on the relationship between ETS exposure and risk for 
developing CVD, T2DM, and MetS, using a large, nationally representative dataset, the 
National Health and Nutrition Examination Survey (NHANES), this study will address this 
gap in the literature.  Because chronic diseases often take time to develop, adolescents have 
lower prevalence of chronic disease.  Therefore, prevention is key in this population.  In 
order to implement cost-effective disease prevention, identification of populations at highest 
risk is often necessary.  If dietary intervention to improve diet quality can mitigate the 
harmful effects of ETS exposure, this would be a strategy which could be employed to 
reduce chronic disease risk amongst the adolescent population.   
2.2 RESEARCH AIMS  
The goal of this study is to gain a better understanding of how ETS and chronic 
disease are related in adolescents.  Specifically, this study seeks to understand differences in 
diet by ETS exposure and how diet affects the relationship between ETS and chronic disease.    
In this investigation, nutrient biomarkers and dietary intake characteristics were examined.  
The nutrient biomarkers included in this research are antioxidant concentrations which have 




will also be examined as folate deficiency is associated with increased homocysteine, and 
increased homocysteine is associated with increased chronic disease risk.  The dietary 
characteristics proposed are modifiable and are known to affect CVD, T2DM, and MetS (43-
46, 71-77, 79, 81, 83, 85-92).  If dietary intake interacts with the effect of ETS on chronic 
disease risk, interventions targeted toward these dietary characteristics could be developed.  
For example, if the alternate Healthy Eating Index 2010 (aHEI 2010) is found to interact with 
the effect of ETS on CVD, it would suggest that ETS-exposed individuals should not only be 
targeted for interventions to reduce ETS exposure, but also for dietary interventions aimed at 
achieving a dietary pattern which aligns with aHEI 2010 characteristics.  Not only will this 
study reveal whether dietary intake interacts with the effect of ETS on chronic disease risk, 
but it may suggest ways in which the harmful effects of ETS on chronic disease risk could be 
mitigated through specific dietary intervention.   
AIM 1: Examine the relationship between ETS and dietary intake and diet quality in 
adolescents. 
H1: Greater exposure to ETS as measured by self-report and cotinine concentrations 
will be associated with lower scores on measures of dietary quality (alternate 
Healthy Eating Index 2010 and DASH diet).  
H2: Greater exposure to ETS will be associated with higher intake of saturated fats 
and lower dietary intake of micronutrients (folate, vitamin C, β-carotene, and α-
tocopherol) and fiber. 
AIM 2: Determine whether nutrient biomarkers mediate the relationship between ETS and 




H1: Greater exposure to ETS will be associated with higher continuous metabolic 
syndrome score and higher prevalence of hypertension, dyslipidemia, and T2DM. 
H2: Greater exposure to ETS will be associated with lower red blood cell folate, 
serum folate, plasma ascorbic acid, and trans-β-carotene concentrations.  
H3: Lower concentrations of red blood cell folate, serum folate, plasma ascorbic acid, 
and trans-β-carotene will be associated with higher continuous metabolic 
syndrome score and higher prevalence of hypertension, dyslipidemia, and T2DM. 
H4: Part of the relationship between ETS and chronic disease risk (continuous MetS 
risk score, hypertension, dyslipidemia, and T2DM) will be mediated by red blood 
cell folate, serum folate, plasma ascorbic acid, and trans-β-carotene concentrations.  
 
AIM 3: Determine whether dietary intake moderates the relationship between ETS and 
chronic disease risk in adolescents. 
H1: Higher scores on measures of quality/patterns of dietary intake (alternate Healthy 
Eating Index 2010, DASH diet) will attenuate the positive association between 
ETS exposure and continuous MetS risk score, hypertension, dyslipidemia, and 
T2DM. 
H2: Greater intake of saturated fats and lower dietary intake of micronutrients (folate, 
vitamin C, vitamin A, and vitamin E) and fiber will exacerbate the positive 
association between ETS exposure and continuous MetS risk score, hypertension, 





Overall, the proposed project will improve scientific knowledge about the 
relationships between ETS, antioxidant concentrations, and chronic disease in adolescents, 
and will help determine whether dietary intake can modify the relationship between ETS and 
chronic disease.  These findings would have implications for public health recommendations 
and regulations.  It may potentially identify target populations (ETS-exposed individuals) for 
strategic dietary intervention.  
 Examining the effects of ETS, dietary intake, antioxidant concentrations, and chronic 
disease risk amongst adolescents is imperative given the impact of these findings.  If dietary 
intake can combat the deleterious effects of ETS on chronic disease risk in adolescents, it 
would warrant interventions which could prevent the development of disease over the life 
course. 
2.3 DATA SOURCE  
This project was carried out using data from the National Health and Nutrition 
Examination Survey (NHANES) years 2001-2006 (126).  NHANES is an ongoing, cross-
sectional, national surveillance survey designed to assess the health and nutritional status of a 
representative sample of adults and children in the United States (127).  The design of 
NHANES includes oversampling of African Americans, Hispanics, and individuals over 60 
years of age to allow for subgroup analyses.  The NHANES sample includes children, 
adolescents, and adults.  The survey combines interviews (self-report responses), dietary 
recall, and physical examinations, with the collection of biologic samples (urine, blood) 
(127).  This dataset includes all of the necessary dietary data, biomarkers of exposure, 
biomarkers of dietary antioxidants, and biomarkers and measures of chronic disease risk 




Data files from NHANES 2001-2002, 2003-2004, and 2005-2006 containing the 
variables needed for this study were downloaded from the NHANES website and merged 
into one file using STATA 13.1.  Data coding and cleaning and statistical analyses were 
completed in STATA 13.1 (128). 
In order to be included in this study, participants were required to have data for the 
exposure (cotinine concentration and self-report) variables and other variables depending on 
the analyses (i.e. mediating variables (nutrient biomarkers), moderating variables (24-hour 
recall data), and outcome (fasting blood panel, blood pressure, and waist circumference 
data)).  Participants aged 12 through <20 years were included in the analyses. 
 Current smokers were excluded from this study as there is no way to distinguish the 
effects of smoking from the effects of ETS.  Pregnant women were also excluded because the 













Biomarkers Exposure Variables: 
o Serum cotinine 
(ng/mL) 
o Self-reported ETS 
exposure 
Moderator Variables: 
o Alternate Healthy Eating Index (aHEI) 
o DASH diet adherence score 
o Fat intake 
o Fiber intake 
o Vitamin C intake 
o Vitamin E intake 
o β-carotene intake 
o Folate intake 
Outcome Variables: 
o Continuous MetS score 
o Hypertension status 
o Dyslipidemia  status 
o T2DM status  
Mediator Variables: 
o Serum ascorbic acid (mg/dL) 
o Serum β-carotene (µg/dL) 
o Serum folate (ng/mL) 






ETS exposure was assessed in NHANES 2001-2006 using a combination of self-
report and cotinine concentrations.  Self-reported tobacco smoke exposure was assessed by 
determining whether anyone who lives in the household smokes and, if so, the number of 
cigarettes smoked inside the home (129-131).  While self-reported ETS exposure is 
important to measure, it is also important to assess ETS using more objective measurements 
due to the stigma associated with smoking.  Smoking prevalence from a study was reported 
earlier based on an objective measure – cotinine concentration.  This study used NHANES 
data as well and reported the self-reported ETS exposure prevalence.  In adults, self-reported 
secondhand smoke exposure (workplace and home combined) ranged from roughly 13 to 16 
percent as compared to 37 to 47 percent based on cotinine concentration.  For adolescents 
aged 12-19, self-reported exposure ranged from approximately 15-23 percent vs. 47-63 
percent exposure based on cotinine concentration (11). 
Cotinine is the major metabolite of nicotine with a half-life of approximately 16-18 
hours after smoking ceases (132).  It is formed from oxidation in the liver and about 70-80 
percent of nicotine is converted to cotinine (132).  Cotinine can be measured in the saliva, 
urine, plasma, and serum of smokers and environmentally exposed non-smokers.  Using 
NHANES data, Mannino et. al. demonstrated that the average number of cigarettes smoked 
in a household was a statistically and clinically relevant predictor of serum cotinine 
concentrations in children (133).  Cotinine concentration can be used to distinguish smokers 
from non-smokers in smoking cessation trials and in epidemiologic studies.  Various cotinine 




A certified phlebotomist performed blood draws in the Mobile Examination Center 
(MEC) for NHANES 2001-2006.  Participants were excluded from blood draws if they had 
hemophilia, received chemotherapy four weeks or fewer prior to the exam date, or if other 
medical conditions were present on their arms (134).  NHANES 2001-2006 had extensive 
quality control plans in place.  Samples from participants were run twice when possible and, 
if the results were in conflict, the sample was run a third (and fourth) time.  Calibration 
materials which qualify under Clinical Laboratory Improvement Amendments (CLIA) were 
utilized, Beckman Coulter® representatives performed quality control checks, an 
Interlaboratory Quality Assurance Program (IQAP) was in place which compared results 
with those of other laboratories, 5C® Cell Control was used, a proficiency testing program 
was in place (College of American Pathologist), freezers were kept between -18 and -23° 
Celsius, and regular automated checks were integrated into the Integrated Survey and 
Information System (ISIS) (135).  Dry runs were conducted during which blind, split samples 
were analyzed in the Mobile Examination Center (MEC).  Specific rules applied when 
running specimens for NHANES called the Westgard rules which are described in the quality 
control protocols for the laboratories.  The National Center for Health Statistics (NCHS) and 
Westat received summary statistics related to quality control quarterly for review (135-137). 
Blood samples collected in red-top tubes were analyzed in the MEC using blind split 
samples.  Contract laboratories performed repeat testing randomly on two percent of the 
samples collected.  Test results below a lower detection limit of any test were replaced by the 
detection limit value divided by the square root of two (135, 137, 138).  
In NHANES 2001-2006, serum cotinine concentrations were determined using ID 




atmospheric pressure chemical ionization tandem mass spectrometry) by the Division for 
Environmental Health Laboratory Sciences at the Centers for Disease Control and Prevention 
(136, 139, 140).  Serum cotinine was derived from blood samples taken from participants 
aged three years and older.  In 2001-2002, the limit of detection for cotinine was 0.05 ng/mL; 
however, during the 2003-2004 cycle and through 2005-2006, the limit of detection for 
cotinine changed to 0.015 ng/mL (136, 139, 140).   
Mediator variables 
 The mediating variables of interest for this study were concentrations of serum 
vitamin C, serum β-carotene, serum α-tocopherol, serum folate, and red blood cell folate.  
Serum folate was measured on participants ages one and older using the Bio-Rad 
Laboratories radioassay kit by the Centers for Disease Control and Prevention Division of 
Environmental Health Laboratory Sciences.  The limit of detection was 0.1 ng/mL for serum 
folate and 20 ng/mL for red blood cell folate (136).   
Serum vitamins A, E, and carotenoids were measured on participants ages six and 
older using liquid chromatography with multi-wavelength photodiode-array absorbance 
detection.  In 2001-2002 and 2005-2006, the National Center for Environmental Health 
performed testing; whereas, in 2003-2004, Craft Technologies performed testing.  Vitamins 
A, E, and carotenoids were measured on participants three and older in 2001-2002 but only 
on participants ages six and older in 2003-2004 and 2005-2006.  For serum vitamin A, the 
detection limit was 1.03 µg/dL, trans-β-carotene was 0.8 µg/dL, and for serum vitamin E it 
was 40.7 µg/dL (141).  Vitamin C was analyzed by the National Center for Environmental 
Health and the Centers for Disease Control and Prevention using isocratic HPLC with 





 The moderating variables of interest included the aHEI 2010 (62, 63), DASH diet 
adherence score (143), saturated fat intake, fiber, vitamin C intake, vitamin E intake, β-
carotene intake, and folate intake.  These were derived using the 24-hour dietary recall data. 
 NHANES 2001-2006 conducted 24-hour dietary recalls using the Automated 
Multiple Pass Method (AMPM) (144).  Respondents reported all foods consumed during the 
previous day from the time the individual woke up until they went to bed.  The five-step 
process began with the interviewer prompting the participant to provide a list of all of the 
foods consumed.  Then, the interviewer guided the respondent through a list of commonly 
forgotten foods to determine if foods were omitted from the initial list.  Details about the 
timing and characterization of the foods were determined in the third step.  During the fourth 
step, tools were utilized to aid the participant in describing the amount of each food 
consumed.  Finally, the interviewer asked one last time whether anything else was consumed 
the previous day during the fifth step (144).   
 Once the AMPM 24-hour dietary recall was complete, NHANES put the data through 
the Post Interview Processing System (PIPS) in order to prepare and code data.  Finally, 
Survey Net was utilized for further coding and quality checks.  Survey Net was also used for 
nutrient analyses.  The combination of AMPM, PIPS, and Survey Net standardized coding 
and allowed for range checks throughout the process (144).  Blanton and colleagues did a 
validation study of the AMPM and found that the AMPM differed less from Doubly Labeled 
Water than other commonly used dietary assessment methods (14 day estimated food record, 
the Block Food Frequency Questionnaire, National Cancer Institute’s Diet History 




in this paper typically underestimated energy intake, and the micronutrient intake estimates 
from the AMPM were higher than those from the other dietary intake assessments (145). 
 All moderating variables were obtained using the dietary data collected during the 24-
hour dietary recall.  Calculations for the aHEI 2010 and the DASH diet adherence score (not 
provided in the raw NHANES datasets) are described in the Data Coding section.  
Outcome measures: MetS, CVD and T2DM 
MetS is a collection of risk factors for CVD and T2DM.  MetS has traditionally been 
examined dichotomously in adults with the following clinical criteria for diagnosis (based on 
the National Cholesterol Education Program’s Adult Treatment Panel): waist circumference 
>102 cm (40 inches) for men and >88 cm (35 inches) for women, triglycerides > 150 mg/dL, 
HDL <40 mg/dL for men and <50 mg/dL for women, blood pressure > 130 systolic /> 85 
diastolic mm Hg, and fasting glucose > 110 mg/dL (146).   
Wijndaele et. al. argued that a continuous MetS score is more valid and should be 
used for epidemiologic studies (147).  Furthermore, because the prevalence of metabolic 
syndrome is lower in the adolescent population (8.6%) than the adult population (21% to 
38.9%) (40), it was prudent to analyze MetS continuously for this study.    
Blood pressure and waist circumference were measured in NHANES 2001-2006 
during the physical examination, and triglycerides, HDL, and fasting glucose concentrations 
were obtained through analyses of blood samples.  In NHANES 2001-2006, all participants 
over eight years of age had their blood pressure measured by a physician in the Mobile 
Examination Center (MEC) (148, 149).  Waist circumference was measured on all 
participants aged two years and older using standardized protocol involving the right ileum 




nearest 0.1 cm (150).  Fasting glucose and insulin were only measured on participants aged 
12 years and older in NHANES whose examination was in the morning (after a nine hour 
fast).  Triglycerides were measured in participants aged 12 and older (151).   The continuous 
MetS risk score was used as the outcome measure of MetS for the adolescents included in 
this study. 
 CVD risk was assessed via hypertension and dyslipidemia status.  Hypertension was 
initially characterized ordinally including normal blood pressure, prehypertension (systolic or 




 percentile for age/height or >120/80 mm Hg), 
Stage 1 hypertension (systolic or diastolic BP readings (different visits) > 95
th
 percentile for 
age/height and < 99
th
 percentile + 5 mm Hg), and Stage 2 hypertension (systolic or diastolic 
BP readings (different visits) >99
th
 percentile for age/height + 5 mm Hg) (38).  Dyslipidemia 
was also initially characterized ordinally including acceptable cholesterol, borderline 
hypercholesterolemia (TC 170-199; LDL 110-129), and hypercholesterolemia (TC > 200; 
LDL >  130) (38).  An ordinal variable was generated initially for T2DM including no 
diabetes, prediabetes (fasting plasma glucose (FPG) 100-125 mg/dL), and diabetes 
(FPG>125 mg/dL) (152).   
Confounding variables 
Analyses were controlled for several potential confounders.  Analyses were adjusted 
for age, gender, and socioeconomic status – all traditionally adjusted for in similar studies 
(108, 110, 116, 118).  Socioeconomic status was assessed using Poverty Income Ratio. All 
analyses were adjusted for race/ethnicity because significant racial differences exist in 
cotinine concentrations amongst the US population with non-Hispanic Blacks having higher 




controlled for in analyses when appropriate.  It is important to adjust for energy intake 
because taking in a lot of calories is associated with micronutrient intake but is also 
associated with obesity which is a direct cause of MetS, CVD, and T2DM.     
2.4 ANALYTIC METHODS  
Data Coding 
In order to minimize risk of misclassification, smokers were excluded from analyses.  
Self-reported smoking was used in conjunction with cotinine concentration since adolescents 
may not readily admit that they smoke due to social stigma, fear of their parents finding out, 
and fear of legal consequences.  Sources from the literature were utilized to identify 
appropriate cut points for distinguishing between smokers and non-smokers.  In 1992, 
Wagenknecht and colleagues published a paper regarding cotinine concentrations in young 
adults.  In the CARDIA study of young adults aged 18-30 years, an overall cutoff of 14 
ng/mL was found to have the highest sensitivity and specificity; however, due to racial 
differences, a cutoff of 9 ng/mL for white participants and 15 ng/mL for Black participants 
was found to be ideal for distinguishing between smokers and non-smokers (153). However, 
more recently, Benowitz and colleagues (2009) analyzed NHANES data, arguing that cutoffs 
may have changed due to changing concentrations of ETS exposure amongst the U.S. 
population with declines in smoking and indoor-smoking bans (154).  Using receiver 
operator characteristic curve analyses applied to NHANES data, Benowitz et. al. came up 
with cut points for adults and adolescents to distinguish smokers from non-smokers.  The cut 
points for adolescents (12 to 19 years) varied by race/ethnicity and gender (154).  The cut 
points used for this study (derived from Benowitz et. al. 2009) were: 8.78 ng/mL for non-




American males, 2.95 for non-Hispanic white females, 2.81 ng/mL for non-Hispanic black 
females, 0.66 for Mexican-American females, and 2.99 ng/mL for other races/ethnicities 
(154). 
The more recent cotinine concentrations described above, in conjunction with self-
reported smoking status, were utilized to exclude smokers from the analyses in this study.  
For those remaining in the dataset, self-report and serum cotinine concentration (analyzed 
continuously) were utilized to assess level of exposure to ETS. 
 Though reference ranges were available for some of the mediating variables of 
interest, all mediating variables (serum α-tocopherol, serum β-carotene, serum folate, red 
blood cell folate, serum vitamin C) were initially evaluated continuously.  The rationale for 
this decision is that a decrease in any one of these variables may have effects on chronic 
disease prior to reaching deficiency.   
 The Alternate Healthy Eating Index score was calculated according to the description 
by McCullough et. al. 2002 (62).  The nine components that make up the aHEI are total fruit, 
total vegetables (excluding potatoes), cereal fiber, ratio of red to white meat, nuts and soy 
protein, multivitamin use, percent calories from trans-saturated fat, polyunsaturated to 
saturated fat ratio, and alcohol.  Points are assigned for each component based on whether 
recommendations were met.  For continuous components, intermediate consumption was 
scored accordingly (i.e., for vegetables, zero servings = zero points, five servings = 10 points, 
and servings between zero and five will receive between zero and 10 points).  The 
components were scored using data from the 24-hour dietary recall in order to permit 




A DASH diet adherence score was calculated for the adolescents based on guidelines 
outlined by Mellen et. al. 2008 and Racine et. al. 2011(143, 155).  Participants earned a point 
for every DASH score target they met for a total of up to nine points.  An intermediate 
DASH accordance score was also calculated.  Participants earned a full point for meeting the 
full DASH score target and half a point for meeting the intermediate target.  The DASH 
score targets (and intermediate targets) were <6% (<11%) kilocalories from saturated fat, 
<27% (<32%) kcals from total fat, >18% (>16.5%) of kcals from protein, <71.4 (<107.1) mg 
cholesterol/1000 kcals, >14.8 (>9.5) g fiber/1000 kcals, <1143 (<1286) mg sodium/1000 
kcals, >238 (>158) mg magnesium/1000 kcals, >590 (>402) mg calcium/1000 kcals, and 
>2238 (>1534) mg potassium/1000 kcals.  Participants were considered DASH accordant if 
their DASH score was 4.5 or higher and intermediately accordant if their intermediate DASH 
score was 4.5 or higher (143, 155). 
The MetS risk score for children was calculated by summing the age, gender, and 
race-adjusted z-scores of the following variables: waist circumference, HDL-C (z-score * -1 
because higher is better), triglycerides, MAP, HOMA-IR (35, 36).  HOMA-IR is a measure 
of insulin resistance calculated using fasting insulin and fasting glucose.  The formula for 
calculating HOMA-IR is: [fasting insulin (μIU/ml) × fasting glucose (mmol/ml)/22.5 (156).   
Hypertension status and hypercholesterolemia status were derived using the National 
Cholesterol Education Program (NCEP) Expert Panel on Integrated Guidelines for 
Cardiovascular Health and Risk Reduction in Children and Adolescents (157).  Participants 
were classified as non-hypertensive if their blood pressure was below the 90
th
 percentile, pre-









their systolic or diastolic was >95
th
 percentile for age and height but less than the 99
th
 
percentile + 5 mm Hg, and Stage 2 hypertension if their systolic or diastolic blood pressure 
reading was >99
th
 percentile + 5 mm Hg for age and height.  Classifications were based on 
the average of their blood pressure readings on the day of the exam (157). 
Dyslipidemia was also assessed as an ordinal variable including acceptable 
cholesterol, borderline hypercholesterolemia (TC 170-199; LDL 110-129), and 
hypercholesterolemia (TC > 200; LDL >  130) using cholesterol values provided in the 
NHANES datasets (39). 
T2DM status was also recoded to an ordinal variable (no diabetes, pre-diabetes, and 
diabetes).  Fasting plasma glucose (FPG) 100-125 mg/dL was coded as prediabetes, and FPG 
>125 mg/dL was coded as diabetes.  FPG less than 100 mg/dL was considered “no diabetes” 
(152).   
Exploratory Data Analyses 
Graphing procedures (i.e., histograms) and simple statistical analyses (measures of 
central tendency, variability, and simple regression analyses) were conducted to examine the 
distribution and relationships between variables.  Specifically, distributions were examined 
for normality and, if not normal, were transformed.  Moderator variables and outcome 
variables which did not already exist in the data were calculated as described above. 
Testing Hypotheses 
All analyses for this study accounted for the complex survey sampling by using 
survey weights ni.  Each person i in the NHANES dataset represents ni persons in the U.S. 




with the disease j; which was interpreted to mean that yij = πij * nij of the nij persons will be 
diagnosed with disease j.     
AIM 1: Examine the relationship between ETS and dietary intake and diet quality in 
adolescents. 
H1: Greater exposure to ETS as measured by self-report and cotinine concentrations 
will be associated with lower scores on measures of dietary quality (alternate 
Healthy Eating Index 2010 and DASH diet).  
H2: Greater exposure to ETS will be associated with higher intake of saturated fats 
and lower dietary intake of micronutrients (folate, vitamin C, β-carotene, and α-
tocopherol) and fiber. 
The hypotheses for aim 1 were tested using multivariable linear regression analyses.  
The first model constructed only included the two variables of interest (i.e., cotinine 
concentration and aHEI score).  The p-value/confidence interval for the β coefficient was 
evaluated.  Then, potential confounders were added to the model.  The β coefficients were 
examined again for significance to determine whether the coefficient for the effect of the 
independent variable of interest was affected by the addition of confounding variables into 
the model. 
The following example model demonstrates how one of the hypotheses was tested: 
E(πij = yij/nij) = β0j + (β1j * ETS) + (β2j…βpj * control variables) …+ Ɛij, where πij is the 
aHEI score of individual i, the β terms are regression coefficients; 0j= average aHEI score 
when cotinine concentration = 0, 1j = the change in average aHEI score per one unit increase 




AIM 2: Determine whether nutrient biomarkers mediate the relationship between ETS and 
chronic disease risk in adolescents. 
H1: Greater exposure to ETS will be associated with higher continuous metabolic 
syndrome score and higher prevalence of hypertension, dyslipidemia, and T2DM. 
H2: Greater exposure to ETS will be associated with lower red blood cell folate, 
serum folate, plasma ascorbic acid, and trans-β-carotene concentrations.  
H3: Lower concentrations of red blood cell folate, serum folate, plasma ascorbic acid, 
and trans-β-carotene will be associated with higher continuous metabolic 
syndrome score and higher prevalence of hypertension, dyslipidemia, and T2DM. 
H4: Part of the relationship between ETS and chronic disease risk (continuous MetS 
risk score, hypertension, dyslipidemia, and T2DM) will be mediated by red blood 
cell folate, serum folate, plasma ascorbic acid, and trans-β-carotene concentrations.  
 
AIM 3: Determine whether dietary intake moderates the relationship between ETS and 
chronic disease risk in adolescents. 
H1: Higher scores on measures of quality/patterns of dietary intake (alternate Healthy 
Eating Index 2010, DASH diet) will attenuate the positive association between 
ETS exposure and continuous MetS risk score, hypertension, dyslipidemia, and 
T2DM. 
H2: Greater intake of saturated fats and lower dietary intake of micronutrients (folate, 
vitamin C, vitamin A, and vitamin E) and fiber will exacerbate the positive 
association between ETS exposure and continuous MetS risk score, hypertension, 




For analyses using a continuous outcome measure (i.e., MetS risk score), 
multivariable linear regressions were used.  When the outcome was ordinal (i.e., no 
hypertension, prehypertension, and hypertension), a logit model was used.  Finally, when the 
outcome was dichotomous (i.e., hypercholesterolemia: yes or no), logistic regression 
analyses were used. 
Mediation was tested using the Sobel and Goodman tests in STATA while adjusting 
for study design (158-160).  The procedure involved estimating ab which is the product of 
the effect of the exposure on the mediator (a) and the effect of the mediator on the outcome 
(b).  The product, ab, was then divided by the square root of the standard error of ab  
to obtain a test statistic to be compared to the normal 
distribution (158, 161-163). 
To test for interaction, an interaction term was included in the regression analyses.  
The interaction term was the product of the exposure and the moderator, and the coefficient 
associated with this product was the “interaction term” (164).  The following example model 
demonstrates how one of the hypotheses related to interaction was tested: E(πij = yij/nij) = β0j 
+ (β1j * ETS) + (β2j * aHEI)+( β3j *ETS*aHEI)+(β4j…βpj * confounding variables) …+ Ɛij, 
where πij is the MetS score of individual i, the β terms are regression coefficients; 0j= 
average MetS score when all other variables = 0 (i.e., aHEI score = 0, cotinine = 0), 1j = the 
change in average MetS score per one unit increase in cotinine concentration when other 
variables in the model are held constant and aHEI = 0, β2j= the change in average MetS score 
per one unit increase in aHEI score holding all other variables constant and cotinine = 0, 3j = 
the coefficient for interaction between aHEI score and cotinine concentration, and ij = error.  
















If the coefficient 3j  is statistically significant, then the relationship between cotinine 
concentration and MetS score differs based on aHEI score. 
Sample size considerations 
Because the analyses were secondary data analyses of data that was already collected, 
the sample size was predetermined.  In sample size calculations and power analysis, the 
variables that influence one another are the size of the sample, the power, and the effect size.  
Typically, when multiple analyses are being performed, the analysis requiring the largest 
sample size is the analysis for which necessary sample size is calculated.  In this study, the 
analysis requiring the largest sample size was the test for interaction between two continuous 
variables (cotinine and aHEI score) in a multiple linear regression with a continuous outcome 
(continuous MetS score). 
Tests of moderation usually have lower effect sizes than other tests with an average 
effect size of approximately 0.009 (165).  When one or both of the variables involved in the 
interaction is continuous, the power given the same sample size and effect size is even lower 
(166).  The equation used to determine detectable effect size for an interaction in multiple 












In the above equation, r
2
 represents the amount of variation in the outcome that can be 
explained by a particular variable or set of variables where r
2
Y.MI is the r
2
 for the combination 
of the main effects of the exposure and the moderator separately and the interaction effect 
and r
2
Y.M is the r
2
 for the main effects of the exposure and the moderator only.  These r
2
 




 In nutrition, R
2
 values are typically low, but can take on a range of values.  For 
example, the R
2
 for a model predicting serum cholesterol increased by 0.05 for men and 0.04 
for women when dietary and lifestyle variables were added to the model (167).  In a study of 
the effects of intakes of foods from various food groups on mammalian lignan enterolactone, 
which is protective against hormone-related cancers, a full model including variables 
representing dietary intake and other covariates (i.e., BMI, smoking), the R
2
 for the full 
models fitted ranged between 0.129 and 0.166 (168).  A study examining the effect of 
saturated fat intake on bone density found R
2
 for the entire model to be 0.18-0.59 depending 
on the measure of bone density taken and other covariates included in the model (169).  





Y.M and the sample sizes required to detect those effect sizes.  In the social sciences, an 
effect size for an interaction term of 0.02 is considered “small”, 0.13 is “moderate”, and 0.35 
is considered “large” (170, 171).  A sample size of n=392 is required to detect an interaction 
effect size of 0.02, n=55 is required to detect f
2
 for interaction of 0.13, and n=26 is required 
to detect f
2




















required to detect 
interaction effect 
0.11769 0.10000 0.0200 
Small 392 
0.21570 0.20000 0.0200 
0.31370 0.30000 0.0200 
0.41179 0.40000 0.0200 
0.50980 0.50000 0.0200 
0.60785 0.60000 0.0200 
0.20357 0.10000 0.1300 
Moderate 55 
0.29205 0.20000 0.1300 
0.38053 0.30000 0.1300 
0.46901 0.40000 0.1300 
0.55753 0.50000 0.1300 
0.64602 0.60000 0.1300 
0.33331 0.10000 0.3500 
Large 26 
0.40740 0.20000 0.3500 
0.48149 0.30000 0.3500 
0.55557 0.40000 0.3500 
0.62964 0.50000 0.3500 
0.70371 0.60000 0.3500 
 
There were 4,692 non-smoking adolescents aged 12 to 19 years with cotinine data in the 
NHANES 2001-2006 datasets.  After applying other exclusion criteria, the smallest sample 
size for any of the analyses for this study was 1,858.  This sample size clearly exceeds the 
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AN EXAMINATION OF THE RELATIONSHIP BETWEEN ENVIRONMENTAL 
TOBACCO SMOKE EXPOSURE AND DIETARY INTAKE AND QUALITY IN 
ADOLESCENTS.  
ABSTRACT 
When examined together, health behaviors such as smoking and diet are correlated.  The 
relationship between environmental tobacco smoke (ETS) exposure and diet quality has 
not been examined in the adolescent population.  Data from 4,663 non-smoking, non-
pregnant adolescents between 12 and 19 years old who had self-reported (SR) ETS 
exposure, cotinine, and 24-hour dietary recall data from the National Health and Nutrition 
Examination Survey (NHANES) years 2001-2006 were utilized to examine whether ETS 
exposure and dietary quality and intake are related in adolescents.  ETS exposure in the 
home was SR by 15.83% (SE 0.01) of adolescents and 47.86% (SE 0.00) had cotinine > 
0.05 ng/mL.  General linear models were run using the svy command in STATA.  SR 
ETS exposure in the home was related to lower Alternate Healthy Eating Index (AHEI) 
2010 score (β = -2.14, 95% CI -3.68, -0.60) and Dietary Approaches to Stopping 
Hypertension (DASH) score (β = -0.23, 95% CI -0.40, -0.05).  Cotinine > 0.05 ng/mL 
was also related to lower diet quality scores (AHEI 2010: β = -1.97, 95% CI -3.05, -0.90; 
DASH: β = -0.25, 95% CI -0.39, -0.12).  SR ETS exposure and cotinine were related to 
higher percent calories from saturated fat and lower total fiber, vitamin C, and β-carotene 
intake.  Cotinine was related to lower total folate intake.  Neither SR ETS exposure or 




exposed to ETS are more likely to have poor diet quality than unexposed adolescents and 
may be at greater risk of chronic disease. 
3.1 INTRODUCTION  
Studies have demonstrated that those who smoke are less likely to be physically 
active, are more likely to consume alcohol, and have poorer diet quality than those who 
do not smoke (1, 2).  There are many theories behind this clustering of health behaviors 
ranging from uni-dimensionality (the belief that someone who values health would 
logically apply that value to multiple health behaviors) to similar environments or 
characteristics (i.e. socioeconomic status) affecting those health behaviors, to biological 
influences (1).   
Secondhand smoke (called environmental tobacco smoke (ETS)) causes a variety 
of negative health outcomes including asthma (3, 4), sleep-disordered breathing (5), 
allergic sensitization (6), cardiovascular disease morbidity and mortality (7-9), lung 
cancer (10), and stroke (11) and increased risk of smoking (12).  A prospective study of a 
cohort of 37,343 women found an association between ETS exposure and diabetes (13).  
Clustering of risk factors or experiences could occur for those exposed to secondhand 
smoke due to familial relationships and shared environments or due to individual-level 
factors.  Since it has been demonstrated that smokers have poorer diets than non-smokers, 
it is possible that secondhand smoke-exposed individuals may also have poorer diets than 
those not exposed to secondhand smoke.  For example, parents can influence their 





Examinations of the differences in biomarkers of micronutrient concentration 
between ETS exposed and unexposed individuals have found that ETS-exposed children 
and adults have lower concentrations of nutrient biomarkers such as vitamins E (17, 18) 
and C (18-22), folate (18, 23, 24), and β-carotene (18, 19, 25, 26) when compared with 
unexposed children and adults.   
The evidence for differences in dietary intake between ETS-exposed and 
unexposed individuals is mixed, sparse, and many of the studies are from 10 years ago or 
more.  A few studies conducted in Europe and Asia have found ETS exposed individuals 
consume fewer vegetables and milk (27, 28), fruit (29), lean meats and complex 
carbohydrates (27), and beans (28) and more fried food (29).  Furthermore, diets of those 
exposed to ETS have been found to be lower in iron, β-carotene (30), and fiber (27).  
However, no differences were observed between the diets of non-smokers who live with 
a smoker when compared to those who live with non-smokers in Japan (31). 
ETS-exposed adults in the United States have lower intakes of fruits and 
vegetables (32-34), consume more fat and cholesterol and less calcium, fiber, and 
vitamins A and C than non-exposed adults (35, 36).  
There are several gaps in the literature regarding differences in dietary intake of 
ETS exposed and unexposed individuals.  The majority of the research in this area has 
focused on female adults.  Studies have not evaluated the differences in diet amongst 
adolescents by ETS exposure.  Furthermore, most studies have utilized self-report to 
assess ETS exposure rather than an objective measure like cotinine concentration.  
Finally, the majority of the studies examined intakes of individual foods and nutrients but 




The goal of this study is to determine whether the diets of adolescents exposed to 
ETS differ from the diets of non-exposed or less-exposed adolescents.  This study will fill 
gaps in the literature by examining this relationship in the adolescent population, by using 
both self-reported and objective (cotinine) measurements of ETS, by examining a large, 
nationally representative sample of the adolescents in the United States including both 
males and females, and by exploring not only differences in intake of individual 
nutrients, but also measures of overall diet quality which are established predictors of 
chronic disease risk.  Hypotheses included that greater exposure to ETS as measured by 
self-report and cotinine concentrations would be associated with lower scores on 
measures of dietary quality (AHEI 2010, DASH diet adherence score) and that greater 
exposure to ETS would be associated with higher intake of saturated fat and lower dietary 
intake of micronutrients and fiber.  
3.2 METHODS  
Study Sample 
NHANES is an ongoing cross-sectional national survey which collects data from 
a representative sample of adults and children in the United States.  NHANES datasets 
are available publicly and include variables that can be used to account for the complex 
sampling design including masked variance pseudo primary sampling unit, masked 
variance pseudo stratum, and survey weights (37, 38).  The survey combines interviews 
(self-report responses), dietary recall, and physical examinations, and the collection of 
biologic samples (urine, blood).  The analyses for this study were conducted amongst 




Survey (NHANES) years 2001-2006 who responded to questions about ETS exposure 
and diet.   
Study Variables 
The variables utilized in this study are derived from the self-reported responses to 
surveys in NHANES, data from the 24-hour dietary recall, and results from laboratory 
tests run on biospecimen samples collected in the Mobile Examination Center (MEC).  
Consent was obtained from adults and assent was obtained from participants ages seven 
through 17 years (39).  
An individual’s ETS exposure was measured in NHANES via self-reported 
exposure and serum cotinine concentration.  These were assessed on all participants ages 
12 years and older, however, blood samples would only be taken from those who did not 
meet any of the exclusion criteria for a blood draw (i.e. hemophilia, chemotherapy within 
the past four weeks, and medical conditions present on their arms)(40-42). Self-reported 
tobacco smoke exposure is assessed by several questions in the NHANES questionnaire.  
For the purposes of this study, the question regarding whether any smokers live in the 
home was utilized to characterize self-reported ETS exposure.  All serum cotinine 
concentrations were determined using isotope dilution-high performance liquid 
chromatography / atmospheric pressure chemical ionization tandem mass spectrometry 
by the Division for Environmental Health Laboratory Sciences at the Centers for Disease 
Control and Prevention.    In NHANES 2001-2002, the limit of detection for cotinine 
changed from 0.05 to 0.015 (43).  The limit was 0.015 for 2003-2006(44, 45).  Because 




have had the opportunity to have a valid value below 0.05, for this study, any values 
below 0.05 were re-coded to the below the detectable limit value.   
Dietary intake is assessed in NHANES using a 24-hour dietary recall which 
utilizes the USDA multiple-pass method (46).  The 24-hour dietary recall is conducted in-
person during the study examination in the Mobile Exam Center (MEC).  The 24-hour 
dietary recall was completed for all participants in person during their study examination 
and then a second recall was conducted telephonically by a phone center (47).  Only 
participants for whom 24-hour dietary recall data was deemed “reliable and met the 
minimum criteria” were included in these analyses (48).  For 2001 data collection, a 24-
hour dietary recall was considered reliable and meeting minimum criteria if fewer than 25 
percent of foods reported lacked descriptions, fewer than 15 percent of reported foods 
had no quantity, and if every meal reported had a minimum of one identified food (48).  
For 2002-2006 data, minimum criteria were that the participant completed at least the 
first four of the five steps of the Automated Multiple Pass Method and that all foods 
reported for all reported meals had to be identified (48).  The NHANES datasets include 
variables quantifying the amount of saturated fat, fiber, vitamin C, vitamin E, β-carotene, 
and folate in the items that the participants reported consuming in the past 24-hour 
period.  Data from the 24-hour dietary recall was utilized to generate the diet 
quality/pattern scores.  To do this, the United States Department of Agriculture (USDA) 
My Pyramid Equivalents Database (MPED) was merged with the NHANES data files 
(49). 
The alternate Healthy Eating Index 2010 (AHEI 2010) score includes nine 




sweetened beverages and fruit juice, nuts and legumes, red/processed meat, trans fat, 
long-chain (n-3) fats (EPA and DHA), polyunsaturated fatty acids, sodium, and alcohol.  
Protocol for scoring for the AHEI 2010 are described elsewhere (50).  Saturated fat 
intake was examined instead of trans fat intake for the purposes of this study as there is 
currently no accurate mechanism for calculating trans fat intake using NHANES 2001-
2006 data.  Reductions in saturated fat consumption have been demonstrated to reduce 
risk for cardiovascular disease (51).  Possible scores for the alternate Healthy Eating 
Index range from 0 to 110. 
 Twenty four-hour dietary recall data were also used to calculate the Dietary 
Approaches to Stop Hypertension (DASH) diet adherence score.  The scoring protocol 
for DASH diet adherence has been described elsewhere (52).  Components involved in 
calculation of DASH diet adherence include percent energy from total and saturated fat 
and protein, magnesium, calcium, sodium, potassium, and cholesterol consumption per 
1,000 calories.  The highest possible adherence score is nine. 
Covariates in these analyses include age, gender, race/ethnicity, and Poverty 
Income Ratio (PIR) category (as an estimate of socioeconomic status) – all concepts 
which have traditionally been adjusted for in similar studies as they are common 
correlates to health behaviors (1, 2, 27, 30).  The demographic portion of the sample 
person questionnaire administered during the study visit includes questions about 
ethnicity (if the respondent considers him or herself to be Hispanic) and race.  The 
NHANES dataset contains a variable which summarizes the participants’ responses to the 
race/ethnicity question where the categories are Mexican American, Other Hispanic, 




Multiple age variables are included in the dataset, but the age in months at the date of the 
exam was utilized for the purpose of this study.  The PIR is the ratio of the total family 
income to the income demarcating poverty as outlined by the Department of Health and 
Human Services guidelines in the Federal Register, adjusted for the size of the family, the 
year, and the state of residence and was used to examine socioeconomic status (53).  All 
distributions were examined for assumptions of normality.  Non-normally distributed 
variables were transformed.  If the transformation did not sufficiently normalize the data, 
then a categorical variable was created and used for analyses.  PIR was categorized into 
three groups: less than 1 (poor), 1 or greater but less than 2 (near poor), and greater than 
or equal to 2 (not poor).   
Sample Size 
Data from NHANES 2001-2006 were combined.  First, children under 12 years of 
age and adults 20 years old or older were excluded, leaving 6,861adolescents.  Other 
exclusion criteria included: positive pregnancy test (n=145), participants whose dietary 
recall data were not deemed reliable (n=302), missing an answer to the question about 
whether anyone in the home smoked (n=79), missing serum cotinine (n=658), self-
reported smoking in the past 5 days (n=804), and missing self-reported smoking in the 
past 5 days (n=611).  Race- and age-specific cotinine cutoffs derived by Benowitz and 
colleagues were used to eliminate potential current smokers from the dataset (54).  After 
removing individuals who did not meet the inclusion criteria for all other reasons 
including self-reported smoking, 342 adolescents were removed from the sample 




/race-specific cutoff.  A total of 4,663 adolescents were included in the sample for this 
study after these exclusions were made.   
Statistical Analysis 
STATA was used for the statistical analyses for this study.  First day dietary recall 
survey weights provided in the dataset were utilized to calculate a 6-year survey weight 
according to NHANES protocol (55).  For analyses where the svy function was available 
in STATA (a function which allows for adjustment for complex survey design and 
weights in statistical analyses), analyses accounted for the 6-year survey weight, masked 
variance pseudo primary sampling unit, and masked variance pseudo stratum.  For 
analyses where the svy function was not available, the 6-year survey weight was used. 
Upon examination, PIR, cotinine concentration, folate intake, vitamin c intake, β-
carotene intake, vitamin E intake, and dietary fiber intake were not normally distributed.  
For all but PIR and cotinine concentration, log10-transformation resulted in a more 
normal distribution.  Even after multiple types of transformations, serum cotinine was 
still not normally distributed.  Because 52.14 percent of the adolescents in the sample did 
not have detectable cotinine, for this study, a binary variable was created to distinguish 
between those who had cotinine values below the detectable limit or <0.05 ng/mL and 
those who had detectable cotinine values >0.05 ng/mL.  Participants whose cotinine 
values were above established cut points used to distinguish between adolescent smokers 
and non-smokers were not included in the sample.  These cut points were: 8.78 ng/mL for 
non-Hispanic white males, 6.01 for non-Hispanic black males, 1.18 for Mexican-




females, and 0.66 for Mexican American females.  No specific cutoff was available for 
other ethnicities, so the general adolescent cutoff of 2.99 ng/mL was used (54).   
The response to the question about whether or not a smoker lived in the home was 
used as a binary measure of self-reported ETS exposure (84.15 percent of the adolescents 
in the sample reported no smokers living in their home).   
To examine the relationship between ETS and dietary intake, general linear 
models were run.  Analyses accounted for probability-based survey strata, clusters, and 
weights using STATA’s SVY command (56).  Analyses were first run with just the 
exposure of interest and the outcome and then potential confounding variables were 
added into the model.  Covariates included in the models were age in years, gender, 
race/ethnicity, and PIR category.       
3.3 RESULTS  
Study Sample Characteristics 
Table 3.1 presents the characteristics of adolescents in the study sample, adjusted 
for study design and weights.  The average age of the adolescents in the sample was 
15.51 years.  The majority of the sample was categorized as not poor; however, 18.93 
percent were at or below poverty level.  The majority of the sample (84.15 percent) 
reported no smokers in their home.  Average cotinine concentration, DASH diet 
adherence score, aHEI 2010 score, and nutrient intakes are also reported in Table 3.1.  
Table 3.2 presents the relationship between self-reported ETS exposure and 
cotinine.  Self-reported ETS exposure was statistically significantly related to cotinine 
>0.05 ng/mL (Design-based Pearson χ
2
 = 830.66, p=0.00) with 51.81% (SE = 2.39) 




reporting that someone does smoke in the home and having cotinine >0.05 ng/mL.  A 
larger proportion of those reporting no ETS exposure in the home had cotinine >0.05 
ng/mL (32.36%, SE = 2.09) than those reporting having a smoker in the home with 
cotinine <0.05 ng/mL (0.32%, SE = 0.08).  This is expected since there are other possible 
sources of ETS exposure (i.e. neighborhood, peers) and since individuals may not be 
willing to admit if someone in the home smokes. 
General Linear Models 
AHEI 2010  
The results from the general linear models examining the relationship between 
self-reported ETS and cotinine and AHEI 2010 score in adolescents are presented in 
Table 3.3.  Self-reported ETS exposure (Model 1) and having a cotinine concentration > 
0.05 ng/mL (Model 2) were both statistically significantly related to lower AHEI 2010 
scores after adjustment for covariates.   
DASH Adherence 
The results from the general linear models examining the relationship between 
self-reported ETS and cotinine and DASH adherence score are presented in Table 3.3.  
Self-reported ETS exposure (Model 1) and cotinine >0.05 ng/mL (Model 2) were both 
statistically significantly related to lower DASH adherence score after controlling for 
potentially confounding variables.   
Nutrient Intakes 
Table 3.3 demonstrates the results from the general linear models examining the 
relationship between binary self-reported ETS, binary cotinine concentration, and 




Having a smoker in the home (Table 3.3) was statistically significantly related to 
a 0.01% higher saturated fat intake when compared to those who did not report having a 
smoker in the home.  Having detectable cotinine >0.05 ng/mL was also associated with a 
statistically significant 0.01% higher intake of saturated fat when compared to those with 
cotinine below 0.05 ng/mL.   
Because the micronutrient intakes were not normally distributed amongst this 
population, nutrient intakes were log-transformed.  The coefficients presented in the 
tables are exponentiated for ease of interpretation.  An exponentiated coefficient above 1 
indicates that the exposure is associated with greater intake and an exponentiated 
coefficient below 1 indicates that the exposure is associated with lower intake of the 
nutrient. 
After adjusting for covariates, having a smoker in the home (compared to no 
smokers in the home) was statistically significantly associated with lower intake of 
vitamin C (-43%, CI -62%, -14%) β-carotene (-49%, CI -65%, -26%) and fiber (-23%, CI 
-38%, -5%) when compared to not having a smoker in the home.  When compared with 
cotinine <0.05 ng/mL or no detectable cotinine, having a cotinine concentration >0.05 
ng/mL was a statistically significant predictor of lower total folate intake (-22%, CI -6%, 
-35%), vitamin C intake (-49%, CI -22%, -67%), β-carotene (-54%, CI -37%, -66%), and 
fiber intake (-32%, CI -22%, -42%) even after controlling for covariates. 
3.4 DISCUSSION  
This is the first study which simultaneously examined the relationship between 
diet quality, nutrient intakes, and secondhand smoke exposure as measured by self-report 




comparing adolescents based on self-reported ETS exposure and exposure defined by 
cotinine concentration found that ETS exposure was associated with poorer diet quality 
as measured by DASH adherence score, AHEI score, lower intake of β-carotene, vitamin 
C, and fiber, and higher intake of saturated fat.  Cotinine concentration >0.05 ng/mL, but 
not self-reported ETS exposure, was found to be associated with lower total folate intake.   
 The findings that ETS exposure was associated with lower intake of fiber (27, 
35), β-carotene (27, 30),  vitamin C (57), and folate (24) are consistent with results from 
studies in adult populations.  Studies that have examined differences in vitamin E intake 
between smokers and non-smokers have had mixed results, with some finding no 
statistically significant difference (58, 59) and others finding that smokers’ intake of 
vitamin E was lower than that of non-smokers (60, 61).  In the analyses, there was no 
significant difference in α-tocopherol intake between ETS-exposed and unexposed 
adolescents.  This is the first study to examine differences in AHEI 2010 score or DASH 
diet adherence between ETS-exposed and unexposed individuals.     
Findings from this study demonstrate that adolescents who are exposed to 
secondhand tobacco smoke may have poorer diet quality.  Clustering of health behaviors 
can lead to interactions between exposures which affect the same health outcome.  This is 
significant from a public health perspective as it identifies a population with multiple risk 
factors for chronic disease.  Both environmental tobacco smoke exposure and poor diet 
quality are risk factors for coronary heart disease and diabetes (50, 62-65).   This suggests 
that perhaps interventions targeting ETS-exposed adolescents to reduce exposure should 
also address improving diet quality in order to maximize benefit for chronic disease risk 




The NHANES dataset is sufficiently large to detect small differences between 
populations.  Furthermore, the population is nationally representative and oversamples 
minority populations and represents all age groups.  However, the cross-sectional nature 
of this data lends itself to reverse causality in analyses.  Therefore, in order to determine 
directionality of the relationships identified in this study, analyses would need to be 
replicated with longitudinal data.  The sample used for this study excluded adolescents 
who self-reported smoking and whose cotinine values were above established cut points 
for suspected active smoking (54).  This decreases the chances that smokers were 
inadvertently included in the analyses, increasing the confidence that the differences are 
by ETS exposure, not active smoking.  However, this also increases the likelihood that 
those who were heavily exposed to ETS may have been excluded from analyses, which 
would reduce the strength of the associations observed. 
There is likely overlap in the mechanisms by which ETS exposure and poor diet 
quality increase risk of chronic disease, suggesting the potential for interaction between 
these exposures and their relationship with chronic disease risk which warrants further 
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Table 3.1 Descriptive characteristics of adolescents from NHANES 2001-2006 adjusted for study 
design 
  
 Study Sample* 
 N=4,663 
Age (months), x̄ (SE) 186.09 (0.86) 
Sex, % (SE)  
Male 51.13 (0.01) 
Female 48.87 (0.01) 
Race/Ethnicity, % (SE)  
Mexican American 12.22 (0.01) 
Other Hispanic 4.68 (0.01) 
Non-Hispanic White 62.61 (0.02) 
Non-Hispanic Black 15.96 (0.02) 
Other race- including multi-racial 5.52 (0.01) 
Poverty Income Ratio category, % (SE)  
>2 61.18 (0.02) 
>1 and <2 19.89 (0.01) 
0-1 (at or below poverty level) 18.93 (0.01) 
Does anyone in the home smoke?, % (SE)  
No 84.15 (0.01) 
Yes 15.83 (0.01) 
Cotinine (ng/mL), x̄ (SE)* 0.27 (0.02) 
Those with cotinine < the highest 
detectable limit, % (SE) 
52.14 (0.03) 
Those with cotinine > the highest 
detectable limit, % (SE) 
47.86 (0.00) 
DASH diet adherence score, x̄ (SE) 2.08 (0.03) 
AHEI 2010 score, x̄ (SE) 25.78 (0.34) 
Saturated fat intake (% of total kcals), x̄ (SE) 11.43 (0.00) 
Fiber intake (grams per 1000 kcals), x̄ (SE) 6.24 (0.07) 
Vitamin C intake (mg per 1000 kcals), x̄ (SE) 40.12 (1.16) 
Folate intake (mg per 1000 kcals), x̄ (SE) 188.48 (3.17) 
β-carotene intake (mg per 1000 kcals), x̄ (SE) 573.76 (26.24) 
Vitamin E intake (mg per 1000 kcals), x̄ (SE) 2.87 (0.04) 
*When using svy command, SE was not estimated due to stratum with single sampling unit.  For this 







Table 3.2 Relationship between self-reported ETS exposure and cotinine >0.05 ng/mL 
 
N=4662  Does anyone in the home smoke? 
  No Yes 
Cotinine 
<0.05 ng/mL 51.81% (SE 2.39) 0.32% (SE 0.08) 
>0.05 ng/mL 32.36% (SE 2.09) 15.52% (SE 1.33) 
    
Design-based Pearson χ
2







Table 3.3. Self-reported ETS exposure and cotinine as predictors of dietary quality and dietary intake
1
 
   





Outcome n β 95% CI n β 95% CI 
AHEI 2010 score 4480 -2.14** -3.68 -0.60 4480 -1.97** -3.05 -0.90 
DASH adherence score 4477 -0.23* -0.40 -0.05 4654 -0.25** -0.39 -0.12 
% kcals from saturated fat 4486 0.01* 0.00 0.01 3048 0.01** 0.00 0.01 
Total fiber intake
4
 4485 0.77* 0.62 0.95 4485 0.68** 0.58 0.78 
Total folate intake
4
 4486 0.87 0.71 1.08 4486 0.78* 0.65 0.94 
Vitamin C intake
4
 4473 0.57** 0.38 0.86 4473 0.51** 0.33 0.78 
β-carotene intake
4
 4475 0.51** 0.35 0.74 4475 0.46** 0.34 0.63 
α-tocopherol
4




 Models adjusted for age, gender, race/ethnicity, and PIR category 
2
 Reference group is those with no reported smoker in the home  
3
 Reference group has no detectable cotinine or cotinine below 0.05 ng/mL 
4 
The outcome variables for these models were not normally distributed and were thus log-transformed.  The coefficients for these models were 
exponentiated for ease of interpretation.  A coefficient above 1.0 means the exposure was associated with higher values for the outcome variable and a 






DO NUTRIENT BIOMARKERS ACT AS MEDIATORS IN THE 
RELATIONSHIP BETWEEN ENVIRONMENTAL TOBACCO SMOKE AND 
CHRONIC DISEASE IN ADOLESCENTS? 
ABSTRACT 
There are known associations between smoking, nutrient biomarkers, and chronic disease 
in adults; however, the relationship between environmental tobacco smoke (ETS) 
exposure, nutrient biomarkers, and chronic disease has not been evaluated in adolescents.  
Data from the National Health and Nutrition Examination Survey (NHANES) years 
2001-2006 were pooled to obtain a sample of 3,992 non-smoking, non-pregnant 
adolescents with blood pressure data and 1,858 adolescents (12-19 years old) with fasting 
blood sample data.  This sample was utilized to determine whether ETS exposure, as 
characterized by self-report and cotinine concentration, is related to chronic disease and 
whether this relationship is mediated by nutrient biomarker concentration.  The majority 
of the sample had normal blood pressure (92.1%) and did not have diabetes (86.3%), and 
47.2% had normal cholesterol.  Linear regressions adjusting for survey design were 
utilized to examine relationships between ETS exposure and chronic disease.  Neither 
self-reported ETS exposure or cotinine > 0.05 ng/mL were statistically significantly 
related to diabetes, cholesterol, or blood pressure status.  Cotinine > 0.05 ng/mL was 
positively associated with metabolic syndrome score with and without adjustment for 
Poverty Income Ratio category.  Serum folate, ascorbic acid, and trans-β-carotene were 
negatively associated with metabolic syndrome score, and red blood cell folate was not 




biomarkers mediated the relationship between ETS exposure and metabolic syndrome 
score and found that serum folate and trans-β-carotene, but not ascorbic acid, were partial 
mediators of this relationship.  This study suggests that ETS exposure is related to 
metabolic syndrome risk and that this relationship may be mediated by nutrient 
biomarkers in adolescents.  Longitudinal studies are needed to examine these 
relationships further. 
4.1 INTRODUCTION  
The link between tobacco smoke and chronic disease risk is well established.  
Smoking increases the risk of elevated blood pressure and metabolic syndrome in 
adolescents (1, 2).  In adults, smoking is related to greater risk of diabetes (3).  Direct 
smoking is not the only way tobacco smoke can impact chronic disease risk; 
environmental tobacco smoke (ETS) exposure is associated with greater risk of 
cardiovascular disease (CVD), type 2 diabetes, and metabolic syndrome in both adults 
and children (2, 4-7).  ETS exposure begins in childhood and adolescence.  It is important 
to better understand the relationship between ETS exposure and risk factors for chronic 
disease in the pediatric population so that it can be addressed properly.    
Exposure to ETS induces oxidative stress, inflammation, platelet aggregation, and 
endothelial dysfunction – all contributors to chronic disease (8). ETS-exposed individuals 
appear to have higher concentrations of two biomarkers of CVD risk, fibrinogen and 
homocysteine, than unexposed individuals (8-10).  A growing body of evidence indicates 
that a possible biological explanation for the relationship between ETS exposure and 
diabetes/metabolic syndrome is the positive association between ETS exposure and 




There is also a demonstrated relationship between ETS exposure and 
concentrations of nutrient biomarkers.  Measures of ETS exposure are associated with 
lower concentrations of folate, vitamin C, β-carotene, and vitamin A (12).  The 
association between ETS exposure and lower nutrient biomarker concentration has also 
been found in children (13).  Several studies have demonstrated a dose-dependent 
negative association between ETS exposure and ascorbic acid concentrations in both 
children and adults (14, 15).  Associations between ETS exposure and ascorbic acid 
concentrations often persist after adjustment for intake (16).  There is also ample 
evidence for lower concentrations of carotenoids in the presence of ETS exposure in both 
adults and children and adolescents after adjustment for intake (12, 13, 16).   
Reduced concentrations of nutrient biomarkers have been associated with chronic 
disease.  There is a biological basis for this relationship; some micronutrients (i.e. retinol, 
α-carotene, and β-carotene) are required for epithelial cell differentiation and cell 
signaling and communication.  Other micronutrients act as antioxidants which shield cell 
membranes from damaging effects on lipid peroxidation (13).  Folate is critical for the 
breakdown of homocysteine – an amino acid that has detrimental effects to vasculature 
(17).  Micronutrients in the blood can reduce cell proliferation and protect against platelet 
adhesion (13).  Epithelial cell differentiation, cell signaling and communication, insulin 
production, oxidation, cell proliferation, and platelet adhesion are all processes which can 
increase risk of CVD, type 2 diabetes, and metabolic syndrome (18).   
As just shown, many of the mechanisms by which low nutrient biomarker 
concentrations affect chronic disease risk overlap with those proposed for ETS exposure 




exposure and chronic disease is mediated by the impact that ETS exposure has on 
nutrient biomarker concentration.  No research to date has examined this potential 
mediating relationship.  If some of the harmful effects of tobacco smoke are a result of 
the effect on micronutrient concentrations, then improvements in diet quality may be able 
to mitigate some of those harmful effects. 
This study will examine the effect of ETS exposure on measures of chronic 
disease risk amongst adolescents and the potential mediating role of micronutrient 
concentrations in this relationship using a large, nationally representative dataset, the 
National Health and Nutrition Examination Survey (NHANES).  
4.2 METHODS  
Study Sample 
NHANES is a cross-sectional national surveillance survey conducted 
continuously across the United States with a complex sampling design including masked 
variance pseudo primary sampling unit, masked variance pseudo stratum, and survey 
weights (19, 20).  The survey involves a combination of self-reported interviews, dietary 
recall, and physical examinations including collection of biologic samples (urine, blood).  
The analyses for this study were conducted amongst participants 12 to 19 years of age 
from the National Health and Nutrition Examination Survey (NHANES) years 2001-2006 
who answered questions about ETS exposure and diet and who underwent a physical 
examination including blood samples.  Consent was obtained from participants who were 
18 years old and older and from guardians of participants under age 18, and assent was 





NHANES involves an interview conducted in participants’ homes and an 
examination by interviewers and medical professionals in a Mobile Examination Center 
(MEC) (22).  This study examined data related to ETS exposure, nutrient biomarkers, and 
chronic disease risk.  One of the ETS exposure variables and the demographic variables 
were obtained via self-report during surveys.  Laboratory test results from biospecimen 
sample data collected during the exam in the MEC were utilized for one of the other 
measures of ETS exposure, for the nutrient biomarker concentrations, and for some of the 
measures of chronic disease risk.  The MEC examination also included anthropometric 
and blood pressure measurements which were utilized for this study as part of the 
metabolic syndrome score.  The adolescents under 18 years of age in this sample 
provided assent and an adult provided consent; adolescents 18 years old or older provided 
consent (21). 
 The NHANES survey includes a demographics portion which includes questions 
about race/ethnicity, household income, age, gender, and other variables.  Some of this 
information was utilized to derive the metabolic syndrome score and some were utilized 
as covariates in analyses.  The first question about race/ethnicity determines whether or 
not the participant considers him/herself to be Hispanic.  The next question asks about 
race.  These questions are combined into a race/ethnicity variable with the following 
categories: Non-Hispanic White, Non-Hispanic Black,  Mexican American, Other 
Hispanic, or Other Race – Including Multi-Racial.  While the NHANES dataset has 
several variables for age, the age in months on the day of the MEC examination was 




Poverty income ratio (PIR) is a variable included in the NHANES dataset as a 
measure of socioeconomic status.  This variable is a ratio of the family income reported 
during the survey to an income specific to the family size, geographic location, and year 
(determined by the Federal Register) (23).  PIR is not normally distributed, so for the 
purposes of this study, a categorical variable was created to represent poor (PIR<1), near 
poor (1<PIR<2), or not poor (PIR>2) (23). 
 The NHANES questionnaire includes multiple questions to assess self-reported 
ETS exposure.  The question utilized for this study read, “I would now like to ask you a 
few questions about smoking.  Does anyone who lives here smoke cigarettes, cigars, or 
pipes anywhere inside this home?”  A self-reported variable from the MEC examination 
about tobacco/nicotine use in the past five days was also utilized to eliminate smokers 
from the dataset.     
Anthropometric measurements are taken during the MEC exam.  For this study, 
waist circumference measurements were utilized to generate the metabolic syndrome 
score.  Exams were taken with the participant wearing an examination gown.  In order to 
standardize waist circumference measurements, NHANES examiners palpate the hip to 
locate a bony landmark on the ilium (where it intersects with the midaxillary line of the 
body) and mark it with a pencil, always taking the measurement from the right side of the 
participant.  A steel measuring tape is then placed around the participant and mirrors are 
utilized to ensure that the tape measure is level.  Examiners are careful to ensure that the 
tape measure is snug without compressing the skin.  Measurements are taken at the end of 




Blood pressure measurements are also taken during the MEC exam.  Participants 
are asked to sit quietly for five minutes prior to blood pressure measurements.  A MEC 
examiner uses a mercury sphygmomanometer to take three to four blood pressure 
measurements using a standardized procedure (25).  For this study, the first blood 
pressure measurement was utilized. 
Blood draws in NHANES are taken from participants three years old and older 
but are restricted to those who did not meet any of the exclusion criteria for a blood draw 
(i.e. medical conditions present on their arms, hemophilia, or chemotherapy within the 
past four weeks).  Self-reported environmental tobacco smoke exposure and cotinine 
concentration are assessed on all participants ages 12 years and older.  NHANES 
methodologies used to determine cotinine and blood cholesterol (26-35) and procedures 
for measurement of blood pressure (23, 28, 36) are described elsewhere.  Briefly, CDC’s 
Division for Environmental Health Laboratory Sciences determines cotinine 
concentration via isotope dilution-high performance liquid chromatography / atmospheric 
pressure chemical ionization tandem mass spectrometry.  Data from NHANES 2001-
2006 was utilized for this study, and during that time period, the limit of detection 
changed from 0.05 ng/mL to 0.015 ng/mL (26).  Due to this change, any value below 
0.05 ng/mL was recoded to be below the detectable limit since individuals with cotinine 
<0.05 ng/mL whose lab tests were performed prior to this change would not have had 
detectable cotinine.    
For analyses involving fasting blood samples (i.e. fasting plasma glucose, insulin, 
cholesterol), the fasting subsample 2-year MEC weights were utilized to calculate a 6-




2-year dietary weights were used to create a 6-year dietary weight for use in analyses.  
The public datasets include variables for these design characteristics which can be used to 
control for sampling design in analyses (20).  Data from the self-reported responses to 
surveys in NHANES, the 24-hour dietary recall, the physical examination, and results 
from laboratory tests run on bio-specimen samples collected in the Mobile Examination 
Center (MEC) were used to derive variables for these analyses.   
A continuous metabolic syndrome score was also calculated by summing the age, 
gender, and race-adjusted z-scores for waist circumference, mean arterial pressure, 
homeostasis model assessment, HDL-cholesterol, and triglycerides (37, 38). 
Because research in Chapter 3 demonstrated that ETS-exposed adolescents have 
different dietary intake and quality when compared to ETS-unexposed adolescents, 
dietary intake variables were also generated using data from the 24-hour dietary recall 
administered as a part of NHANES in the MEC.  The 24-hour dietary recall used in 
NHANES utilizes the multiple pass method developed by the USDA (39).  Included in 
the NHANES dataset is summary nutrient information indicating, from the foods and 
beverages reported, how much vitamins A, C, E, and folate was consumed in the 
preceding 24-hours (40).  For an approximate measure of “adequacy” of intake of the 
micronutrient of interest, the participants’ intake was compared to the Recommended 
Dietary Allowance (RDA) from the National Academy of Sciences’ Dietary Reference 
Intakes based on the age and gender of that participant.  Dichotomous variables were 
created to represent whether or not the participant met the RDA for each nutrient being 




needs of approximately 98 percent of the population (42).  These variables were utilized 
as covariates in the mediation analyses.   
Variable distributions were evaluated for normality.  Any non-normally 
distributed variables were log-transformed.  If log-transformation did not normalize the 
variable, other transformations were attempted, and for those which could not be 
normalized, a dichotomous or categorical variable was created.   
Sample Size 
After combining data from NHANES 2001-2006 and eliminating adults (20 years 
old and older) and children (less than 12 years of age), 6,861adolescents remained in the 
dataset.  Individuals were excluded if they had a positive pregnancy test (n=145), a 
dietary recall data deemed “not reliable” (n=302), missing self-reported ETS exposure in 
the home (n=79), missing serum cotinine (n=658), if they reported smoking in the past 5 
days (n=804), or if there was no data for self-reported smoking in the past 5 days 
(n=611).  Potential smokers were eliminated from the dataset (1,783 adolescents) based 
on age-/race-specific cotinine cutoffs (43).  Of the 4,663 adolescents remaining, for 
analyses where metabolic syndrome score, cholesterol, or diabetes were the outcomes, 
additional exclusions were applied for those adolescents missing total cholesterol (n=20), 
LDL cholesterol (n=2,503), triglyceride (n=2,442), HDL-cholesterol (n=20), blood 
pressure (n=671), or a 2-year fasting subsample weight (n=2427), leaving 1,858 
adolescents in the sample.  For this paper, this sample is referred to as the “fasting 
sample”. For analyses where blood pressure was the outcome variable, only those 
missing blood pressure were excluded, leaving a sample of 3,992 adolescents in the 





Statistical analyses were conducted using STATA.  Distributions of variables 
were examined to determine if they were normally distributed.  The variables were 
examined separately for both samples (fasting sample and blood pressure sample).  
Metabolic syndrome score, red blood cell folate, serum folate, and serum ascorbic acid 
were all normally distributed for both samples.  Several variables were transformed or 
categorized due to a non-normal distribution.  Poverty income ratio was categorized into 
less than 1 (poor), 1 or greater but less than 2 (near poor), and greater than or equal to 2 
(not poor).  In both the blood pressure sample and the fasting sample, the proportion of 
adolescents with cotinine < 0.05 ng/mL was just over 50 percent.  As a result, cotinine 
was converted to a binary variable where those with non-detectable cotinine or cotinine 
under 0.05 ng/mL had a value of 0 and those with cotinine > 0.05 ng/mL had a value of 1.   
Mediation analyses were performed in Stata using the sgmediation command to 
run Sobel-Goodman tests with the svy prefix to account for survey design (44).  If a 
represents the coefficient when the mediating variable is regressed on the independent 
variable and b represents the relationship when the dependent variable is regressed on the 
mediating variable, the Sobel test is the ratio of the product of ab to the estimate of the 
standard error of ab (45, 46).    
4.3 RESULTS  
Study Sample Characteristics 
Descriptive statistics for the fasting study sample and the blood pressure sample 
are presented in Table 4.1.  The mean age of the adolescents in the fasting sample was 




185.94 months (15.50 years; SE = 0.89 months).  Both samples were roughly half male, 
half female with slightly more males than females.  Over 60 percent of both samples had 
a Poverty Income Ratio (PIR) greater than 2 (2 times the poverty level) and under 20 
percent of both samples had a PIR at or below poverty level.  Only 14.17 percent (SE = 
0.02) of the fasting sample and 15.96 percent (SE = 0.01) of the blood pressure sample 
reported that anyone in the home smoked.  Just under half of each sample had cotinine 
that was greater than or equal to 0.05 ng/mL.   
Table 4.2 presents descriptive statistics for the measures of chronic disease risk 
and concentrations of micronutrients.  The mean continuous metabolic syndrome score 
was -0.14 (SE = 0.13) in the fasting study sample.  As expected, the majority of the 
sample had normal blood pressure (92.05%) and 5.38% were pre-hypertensive, 2.10% 
were Stage 1 Hypertensive, and 0.47% had Stage 2 hypertension.  Based on total 
cholesterol, LDL-cholesterol, and triglyceride, 47.23% of the sample had normal 
cholesterol, 30.79% had borderline high cholesterol and 21.98% had high cholesterol.  
Less than one percent of the sample had diabetes (0.52%), 13.22% had pre-diabetes, and 
86.26% did not have diabetes.   
Environmental Tobacco Smoke Exposure and Chronic Disease Risk 
 Prior to examining the potential mediating effects of concentrations of nutrients in 
the relationship between environmental tobacco smoke and chronic disease risk, analyses 
were conducted to verify that relationships between ETS and measures of chronic disease 
did exist amongst this population.  For ETS and continuous metabolic syndrome score, 
linear regressions were conducted adjusting for survey design with and without 




because those are all factors used to generate the metabolic syndrome score.  Self-
reported ETS was not statistically significantly related to continuous metabolic syndrome 
score; however, cotinine > 0.05 ng/mL was associated with higher metabolic syndrome 
score before (β = 0.31, 95% CI 0.05, 0.58) and after (β = 0.29, 95% CI 0.01, 0.56) 
adjustment for poverty income ratio category (results not shown).   
Because such a small proportion of the population had diabetes and the proportion 
of the population with pre-hypertension and Stage 1 and Stage 2 hypertension was also 
extremely low, diabetes and blood pressure status were dichotomized into no diabetes vs. 
pre-diabetes/diabetes and normal blood pressure vs. pre-hypertension/hypertension 
(stages 1 and 2).   
Self-reported ETS exposure was not statistically significantly related to blood 
pressure (OR=0.88, CI 0.48, 1.60) even after adjustment for race/ethnicity and PIR 
category (OR=0.92, CI 0.50, 1.70).  Cotinine was also not statistically significantly 
associated with blood pressure (OR=1.12, CI 0.78, 1.62) after adjustment for 
race/ethnicity and PIR category (OR=1.12, CI 0.82, 1.80).  Gender and age were not 
included in these models since these are used directly in determining blood pressure 
status.   
Self-reported ETS exposure was not found to be associated with diabetes 
(OR=0.65, CI 0.39, 1.08) even after adjustment for sex, age, race, and PIR category 
(OR=0.67, CI 0.40, 1.12).  Cotinine greater than or equal to 0.05 ng/mL was also not 
statistically significantly related to diabetes (OR=1.32, CI 0.96, 1.84) after adjustment for 




Self-reported ETS exposure was not found to be associated with borderline or 
high cholesterol (OR=1.16, CI 0.91, 1.46) even after adjustment for sex, age, 
race/ethnicity, and PIR category (OR=1.18, CI 0.92, 1.50).  Cotinine >0.05 ng/mL was 
also not associated with cholesterol (OR=1.16, CI 0.84, 1.62) after adjustment for the 
same covariates (OR=1.07, CI 0.74, 1.53).   
Nutrient Concentration and Chronic Disease Measures 
 Before analyzing whether or not nutrient biomarker concentrations mediate the 
relationship between ETS exposure and metabolic syndrome, analyses were conducted to 
verify an association between nutrient concentrations and metabolic syndrome.  Linear 
regression analyses were conducted with and without covariates, controlling for study 
design, to determine whether red blood cell folate, serum folate, ascorbic acid, or trans-β-
carotene concentration were statistically significantly related to metabolic syndrome 
score.  Red blood cell folate was not statistically significantly associated with metabolic 
syndrome score even after adjustment for PIR category.  Increased serum folate was 
associated with lower metabolic syndrome score (β = -0.06, CI -0.09, -0.03) even after 
adjustment for PIR category (β = -0.06, CI -0.08, -0.03).  Higher ascorbic acid 
concentration was also associated with lower metabolic syndrome score (β = -0.80, CI -
1.37, -0.23) after adjustment for PIR category (β = -0.81, CI -1.38, -0.24).  Similarly, 
higher trans-β-carotene was associated with lower metabolic syndrome score (β = -1.12, 
CI -1.41, -0.84) after adjustment for PIR category (β = -1.13, CI -1.42, -0.84). 
Mediation 
Table 4.3 presents the results from the mediation analyses.  Since serum folate, 




significantly related to metabolic syndrome score, these variables were examined as 
potential mediators in the relationship between cotinine and metabolic syndrome.  Just 
over 30 percent (30.2%) of the total effect of cotinine on metabolic syndrome score was 
mediated by serum folate concentration.  The coefficient for the Sobel test was 0.1 and 
the p-value was <0.01.  The relationship between cotinine and metabolic syndrome score 
was also mediated by trans-β-carotene with 67.2 percent of the total effect being 
mediated, a Sobel coefficient of 0.2, and a p-value <0.01.  The Sobel coefficients 
remained statistically significant even after adjustment for PIR and meeting the RDA for 
folate and vitamin A intake respectively (see Table 4.3).  The Sobel coefficient for 
analyses examining whether serum ascorbic acid mediates the relationship between ETS 
and metabolic syndrome was not statistically significant (Sobel coefficient of 0.05, 
p>0.05) with or without adjustment for PIR and meeting the RDA for vitamin C.   
4.4 DISCUSSION  
This study sought to evaluate whether the impact of ETS exposure on chronic 
disease risk is mediated by micronutrient concentration.  Analyses did not identify a 
statistically significant relationship between self-reported ETS exposure and chronic 
disease measures.  The only measure of chronic disease found to be associated with 
cotinine was continuous metabolic syndrome score.  Examination of the relationship 
between micronutrient concentration and metabolic syndrome score revealed that serum 
folate, ascorbic acid, and trans-β-carotene were all inversely related to metabolic 
syndrome score.  Subsequent investigation into potential mediating relationships found 
that the relationship between cotinine and metabolic syndrome score was partially 




The lack of association between ETS exposure and blood pressure, cholesterol, 
and diabetes in this study does not necessarily rule out the possibility that ETS exposure 
can increase risk for these conditions.  These conditions all have relatively low 
prevalence in the adolescent population as compared to the adult population since they 
develop over time.  Other studies which have examined the relationship between ETS 
exposure and blood pressure in adolescents have also found that while it appeared that 
ETS exposure was related to increased blood pressure, the relationship did not reach 
statistical significance (1).  It is possible that the effect of the ETS on chronic disease 
takes time to manifest itself.  A study of French women found higher incidence of type 2 
diabetes amongst women who reported exposure to ETS during childhood (47).  The 
exposure amongst the women in that study was also greater than the exposure in this 
sample with 58 percent of the sample in the Lajous study reporting exposure to ETS 
during childhood as compared to under 20 percent of this sample reporting that someone 
in the home smokes. 
While the blood pressure, cholesterol, and diabetes variables in this study were 
dichotomous, the metabolic syndrome score utilized in this study is a continuous measure 
of chronic disease risk taking into account subclinical risks related to blood pressure, 
insulin resistance, and cholesterol and therefore would allow for detection of associations 
that may be missed when examining clinical disease cutoffs.   
Weitzman and colleagues used a dichotomous characterization of metabolic 
syndrome and found that ETS exposure resulted in a 4.7-fold increase in prevalence of 
metabolic syndrome (CI, 1.7 to 12.9) when compared to ETS-unexposed adolescents as 




syndrome continuously, but also found that cotinine >0.05 ng/mL was associated with 
increased metabolic risk.   
Wilson and colleagues found that vitamin C, vitamin E, cis-β-carotene, trans-β-
carotene, and folate were all lower with increasing exposure to ETS (12).  This supports 
the argument that part of the relationship between ETS exposure and chronic disease risk 
may be mediated by decreases in micronutrient concentration.     
There is evidence for the biological plausibility of a mediating relationship 
between ETS exposure, micronutrient concentration, and chronic disease risk.  In vitro, 
free radicals contained in tobacco smoke reduce antioxidant concentration in plasma (48).  
Depleted vitamin C concentration is associated with inflammation, atherosclerosis, and 
peripheral arterial disease (49).  In analysis of NHANES data, Ford and colleagues 
discovered an association between c-reactive protein (a marker of inflammation) and 
lower concentration of vitamin C and β-carotene, amongst other micronutrients (50).  
Ford and colleagues also found in yet a different study of adult NHANES participants 
that metabolic syndrome was associated with lower concentrations of carotenoids and 
vitamin C (50).  As Roberts and Sindhu explained in their mini review of oxidative stress 
and metabolic syndrome, oxidative stress plays a key role in the development of 
hypertension, diabetes, and atherosclerosis (18).  Therefore, it is logical that depletion of 
nutrients which function as antioxidants would be associated with increased risk of these 
diseases. 
 NHANES is a large, nationally representative dataset.  This study investigated 
relationships between ETS exposure and chronic disease using two different 




concentration is a more objective measurement of ETS exposure than self-report.  Yet 
another strength of this study is the use of both clinical cutoffs/definitions of chronic 
disease like hypertension, diabetes, and hypercholesterolemia as well as a subclinical 
indicator of chronic disease risk – continuous metabolic syndrome score.  The use of the 
continuous metabolic syndrome score in this study is especially important given that the 
population of interest was adolescents.  ETS exposure may have a gradual effect on 
chronic disease risk over time which may not present as clinical disease until adolescents 
reach adulthood.  However, by examining continuous metabolic syndrome score, this 
study was able to examine whether there were trends for harmful effects of ETS exposure 
on chronic disease risk before development of full blown disease, and whether these 
harmful effects were mediated by nutrient concentration.   
The cross-sectional nature of the NHANES data poses the potential for 
identification of relationships which are not causal in nature due to the lack of 
temporality.  Future studies which first characterize ETS exposure and later assess 
nutrient concentration and chronic disease risk would provide stronger evidence for 
causality in the mediation relationship observed here. 
 The potential mediating relationship between ETS exposure, nutrient 
concentrations, and chronic disease suggests that these relationships should be evaluated 
further using longitudinal data.  More importantly, if part of the harmful effect of ETS 
exposure on chronic disease risk is mediated by nutrient concentrations, this suggests the 
possibility that a diet with adequate or higher micronutrients (specifically folate, ascorbic 
acid, and trans-β-carotene) could mitigate these harmful effects.  Further research should 




healthier diet overall can reduce the harmful effects of ETS exposure on chronic disease 
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Table 4.1 Descriptive characteristics of adolescents from NHANES 2001-2006 adjusted for study 
design 
  
 Fasting study sample* Blood pressure sample* 
 N=1,858 N=3,992 
Age (months), x̄ (SE) 186.41 (0.94) 185.94 (0.89) 
Sex, % (SE)   
Male 50.35 (0.02) 51.38 (0.01) 
Female 49.65 (0.02) 48.62 (0.01) 
Race/Ethnicity, % (SE)   
Mexican American 12.01 (0.01) 12.26 (0.01) 
Other Hispanic 3.72 (0.01) 4.24 (0.01) 
Non-Hispanic White 62.64 (0.02) 63.73 (0.02) 
Non-Hispanic Black 14.93 (0.02) 14.31 (0.02) 
Other race- including multi-racial 6.70 (0.01) 5.47 (0.01) 
Poverty Income Ratio category, % (SE)   
PIR greater than 2 (2*poverty level) 61.53 (0.02) 61.29 (0.02) 
PIR greater than poverty level (1) but 
less than or equal to 2 (2*poverty level) 
21.60 (0.01) 19.90 (0.01) 
PIR 0 to 1 at or below poverty level  16.87 (0.01) 18.81 (0.01) 
Does anyone in the home smoke?, % (SE)   
No 85.83 (0.02) 84.04 (0.01) 
Yes 14.17 (0.02) 15.96 (0.01) 
Cotinine (ng/mL), % (SE)   
<0.05 ng/mL 50.88 (0.03) 51.92 (0.02) 
>0.05 ng/mL 49.12 (0.03) 48.10 (0.02) 
*Blood pressure sample = eligible adolescents with cotinine and self-reported ETS data, valid 24-hour 
dietary recall data, and blood pressure values; Fasting study subsample = eligible adolescents from the 




Table 4.2 Descriptive characteristics of adolescents from NHANES 2001-2006 adjusted for study 
design 
  




 N=1,858 N=3,992 
Continuous MetS risk score, x̄ (SE) -0.14 (0.13) - 
Blood pressure status, % (SE)** - - 
Normal blood pressure - 92.05 (0.01) 
Pre-hypertension - 5.38 (0.01) 
Stage I Hypertension - 2.10 (0.00) 
Stage II Hypertension - 0.47 (0.00) 
Cholesterol status, % (SE)**  - 
Normal cholesterol 47.23 (0.02) - 
Borderline hypercholesterolemia 30.79 (0.02) - 
Hypercholesterolemia 21.98 (0.02) - 
HDL status, % (SE)** - - 
Normal 67.28 (0.02) - 
Borderline low 17.93 (0.01) - 
Low 14.79 (0.01) - 
Diabetes status, % (SE)** - - 
No diabetes 86.26 (0.01) - 
Pre-diabetes  13.22 (0.01) - 
Diabetes 0.52 (0.00) - 
Red blood cell folate, x̄ (SE) 247.45 (4.16) 251.73 (3.72) 
Serum folate, x̄ (SE) 12.63 (0.24) 13.15 (0.19) 
Ascorbic acid , x̄ (SE) 1.01 (0.02) 1.06 (0.02) 
Trans-β-carotene, x̄ (SE) 12.30 (0.35) 12.16 (0.21) 
*Fasting study sample = eligible adolescents with cotinine, self-reported ETS data, valid 24-hour dietary 
recall data, and fasting blood draw data; Blood pressure sample = eligible adolescents with cotinine, self-
reported ETS data, valid 24-hour dietary recall data, and blood pressure data  




Table 4.3. Sobel test for mediation relationship between ETS, nutrient biomarkers, and MetS 
  
Mediator Sobel coefficient Standard error P-value 
Percent of total 
effect that is 
mediated 
Folate 0.1 0.0 0.00* 30.2 
Folate
1
 0.1 0.0 0.02* 28.8 
Ascorbic acid 0.1 0.0 0.10 15.2 
Ascorbic acid
2
 0.1 0.0 0.10 16.3 
Trans-β-carotene 0.2 0.1 0.00* 67.2 
Trans-β-carotene
3
 0.2 0.1 0.00* 65.9 
*Statistically significant at the 0.05 level 
1
Adjusted for PIR and whether or not participant met the RDA for folate 
2
Adjusted for PIR and whether or not participant met the RDA for vitamin C 
3









DO MEASURES OF DIET QUALITY OR DIETARY INTAKE MODERATE THE 
RELATIONSHIP BETWEEN ENVIRONMENTAL TOBACCO SMOKE 
EXPOSURE AND METABOLIC SYNDROME RISK IN ADOLESCENTS? 
ABSTRACT 
Both dietary intake and environmental tobacco smoke (ETS) exposure affect chronic 
disease risk.  Using data from the 2001-2006 National Health and Nutrition Examination 
Surveys, this study examined whether there is an interaction between diet quality/intake 
and ETS exposure in their relationship with chronic disease risk in non-smoking, non-
pregnant adolescents ages 12-19 years.  Data analyses were performed using STATA.  
General linear models adjusting for study design were utilized to examine potential 
interactions between ETS exposure, as characterized by self-report and cotinine 
concentration, and dietary quality (as characterized by alternate Healthy Eating Index 
score and Dietary Approaches to Stopping Hypertension score) and intake (fiber, 
vitamins A, C, and E, and folate).  While meeting the Recommended Dietary Allowance 
(RDA) for dietary folate equivalents (DFEs) was negatively associated with metabolic 
syndrome score, none of the interactions tested were statistically significant even after 
adjustment for poverty income ratio (PIR) category and supplement use.   
5.1 INTRODUCTION  
Dietary intake and environmental tobacco smoke (ETS) exposures affect risk of 
chronic diseases including metabolic syndrome.  Findings in Chapter 3 demonstrated that 
adolescents exposed to ETS also have diets of poorer quality than those who are 




study also found that ETS exposure is associated with higher metabolic syndrome score 
in adolescents; this is consistent with findings in the literature demonstrating that ETS 
contributes to insulin resistance, hypercholesterolemia, endothelial dysfunction, and 
increased coagulation, and is associated with metabolic syndrome in adolescents (1).  
Research in Chapter 4 showed that the relationship between ETS and metabolic 
syndrome was partially mediated by serum folate, ascorbic acid, and trans-β-carotene 
concentrations which is supported by other studies in the literature (2).  Since part of the 
effect of ETS exposure on metabolic syndrome was related to nutrient biomarkers, it is 
possible that diet quality may impact the effect of ETS exposure on metabolic syndrome.     
Folate is required for the breakdown of homocysteine (3).  Elevated homocysteine 
concentration is thought to impact chronic disease by promoting blood clot formation, 
inflammation, creating oxidative stress, causing smooth muscle cells to multiply rapidly, 
and affecting vasodilation and constriction in the endothelium (4).  Variations in 
antioxidant concentrations also impact chronic disease risk.  Oxidative stress results from 
an imbalance between the oxidative stress and antioxidant capacity in the body.  Research 
indicates that oxidative stress is associated with insulin resistance, adiposity, total body 
fat, waist circumference, endothelial dysfunction, lipoprotein atherogenicity, and arterial 
blood pressure – all components of metabolic syndrome (5).  Conversely, micronutrient 
concentration can reduce cell proliferation and protect against platelet adhesion (6).  
Individuals with chronic metabolic diseases have lower concentrations of vitamin C, 
carotenoids, and α-tocopherol (5, 7, 8).   
 Dietary intake can also influence metabolic syndrome risk.  The Dietary 




American Heart Association due to observed positive impacts on blood pressure, 
oxidative stress, inflammation, insulin sensitivity, and cholesterol concentrations (9).  
The Alternate Healthy Eating Index has been associated with significantly lower risk of 
chronic disease – specifically coronary heart disease and diabetes (10). Fiber, vitamin C, 
and vitamin E intake are inversely related to metabolic syndrome in adolescents (11, 12).  
Antioxidant supplementation has been associated with improvement in flow-mediated 
dilation of the brachial artery, reductions in hypertension, arterial stiffness, and insulin 
resistance (5).  Some animal, in vitro, and human research supports the potential for 
dietary intake – specifically fiber and antioxidants - to modify the effect of ETS exposure 
on chronic disease risk (13-15); however, evidence for interaction between these 
exposures is mixed (16).  
 The goal of the present study is to test the potential interaction between diet 
quality and intake and ETS exposure as they relate to metabolic syndrome score using a 
large, nationally representative sample of adolescents from the National Health and 
Nutrition Examination Survey (NHANES).  The measures of diet quality to be examined 
as potential effect modifiers in this study include Dietary Approaches to Stopping 
Hypertension (DASH) adherence score, the Alternate Healthy Eating Index (AHEI) 2010 
score, and whether or not individuals consumed recommended amounts of fiber, vitamin 
C, folate (dietary folate equivalents), β-carotene (retinol activity equivalents), and 
vitamin E for their age/gender.   





The National Health and Nutrition Examination Survey (NHANES) is a 
nationwide survey conducted in the United States which gathers health and nutrition data 
on a representative sample of adults and children through interviews, examinations, 
dietary recall, and biospecimen collection.  A complex survey design is utilized in order 
to ensure that sufficient participants from minority groups are included to allow for sub-
analysis.  The publicly available datasets include masked variance pseudo primary 
sampling unit, masked variance pseudo stratum, and survey weights which can be utilized 
to adjust for the complex survey design in analyses (17, 18).  This study utilized 
NHANES 2001-2006 data and included participants ages 12 to <20 years who had ETS 
exposure, dietary recall, and fasting biospecimen data available.   
Study Variables 
The diet quality and intake variables utilized in this study were derived from the 
24-hour dietary recall data.  Metabolic syndrome score was calculated using variables 
from the biospecimen samples and anthropometric measurement data collected in the 
Mobile Examination Center (MEC).  The ETS exposure variable is also from blood 
samples collected in the MEC.    Adolescents 18 years old or older provided consent; 
adolescents younger than 18 years of age provided assent and their parents provided 
consent for participation (19). Blood samples were obtained from participants ages 12 
years and older who did not have medical conditions on their arms, had not had 
chemotherapy in the past four weeks, and did not have hemophilia (20-22). 
ETS exposure was quantified for this study using the serum cotinine 
concentration values.  The Division for Environmental Health Laboratory Sciences at the 




performance liquid chromatography / atmospheric pressure chemical ionization tandem 
mass spectrometry to assess serum cotinine.  The limit of detection changed during 
collection years 2001-2002 from 0.05 ng/mL to 0.015 ng/mL and remained at 0.015 
ng/mL from 2003-2006  (23-25).     
A well-tested 24-hour dietary recall method called the USDA automated multiple-
pass method (AMPM) was utilized to collect dietary intake data for NHANES during the 
exam in the MEC and then again by phone by a phone center (26).  Participants whose 
dietary recall data was not deemed “reliable and met the minimum criteria” were 
excluded from these analyses.  In 2001, in order to be considered reliable and meet 
minimum criteria, descriptions needed to be provided for 75 percent or more of foods 
reported, quantities needed to be provided for 85 percent or more of reported foods, and 
meals had to include at least one identified food (27).  In 2002-2006, four of the five 
AMPM steps had to be completed and all foods for all meals needed to be identified (27).  
The NHANES datasets include summary variables indicating the amount of individual 
nutrients in all of the foods the participants reported consuming in the 24-hour period 
along with whether or not the participant reported taking any dietary supplements in the 
past 30 days.  Twenty-four hour recall data from NHANES and United States Department 
of Agriculture (USDA) My Pyramid Equivalents Database (MPED) data were utilized to 
create the diet quality/pattern scores (28).   
The NHANES dataset contains variables indicating participants’ intake of fiber, 
dietary folate equivalents (DFE), retinol activity equivalents (RAE), and vitamins C and 
E based on the foods they reported during their 24-hour dietary recall.  The National 




recommendations for intake of various nutrients based on individuals’ age and gender 
(29).  These DRIs are based on available data and informed decisions.  The goal is not 
only to prevent disease, but to also achieve optimum health (29).  The DRIs include 
Estimate Average Requirements (EAR), Recommended Dietary Allowances (RDAs), and 
Adequate Intakes (AIs).  The EAR is the amount of a nutrient thought to meet the needs 
of 50 percent of the population.  RDAs are the EAR plus two standard deviations and are 
thought to meet approximately 98 percent of the population’s nutritional needs (30).  
When insufficient data exist to designate a RDA for a nutrient, an AI is set which is 
thought to meet the requirements of most individuals of that age and gender (30).   
Rather than assess nutrient intakes continuously, the variables in the dataset 
indicating intake of DFEs, RAEs, vitamins C and E, and fiber were compared to the DRIs 
and variables were created to indicate whether or not the RDA (for DFEs, RAEs, 
vitamins C and E) and AI (for fiber) were met (29).  The variables were not normally 
distributed.  Furthermore, it is possible that consuming adequate amounts of these 
nutrients would be the important factor in these relationships and that the relationships 
may not be continuous. 
The alternate Healthy Eating Index 2010 score was developed specifically to be 
predictive of chronic disease risk by encompassing components already known to be 
associated with chronic disease risk such as fruit and vegetable, whole grain, nuts and 
legumes, red/processed meat, trans fat, long-chain (n-3) fats, polyunsaturated fatty acids, 
sugar-sweetened beverages and fruit juice, sodium, and alcohol consumption.  One 
substitution was made from the scoring protocol described by Chiuve et. al. – saturated 




information about trans-fatty acid intake (10).  Saturated fat intake is also related to 
chronic disease risk, so this substitution is appropriate for the purposes of this study (31).  
Alternate Healthy Eating Index scores can range from 0 to 110. 
 Scoring protocols for the Dietary Approaches to Stopping Hypertension (DASH) 
diet adherence score have been described elsewhere (32).  Twenty four hour dietary recall 
data from NHANES were utilized to develop this score which draws on the following 
intake components: calcium, magnesium, potassium, sodium, and cholesterol per 1,000 
calories and percent of calories from saturated and total fat and protein.  The highest 
possible score for DASH adherence is nine. 
 Continuous metabolic syndrome score was calculated for the sample of 1,889 
non-smoking (by self-report and cotinine values), non-pregnant adolescents between 12 
and 19 years of age with reliable dietary recall data, questionnaire data on ETS exposure, 
cotinine data, and blood pressure, waist circumference, glucose, insulin, triglyceride, and 
HDL-cholesterol data.  The score was calculated per guidelines presented by Eisenmann 
et. al. (33).  First, blood pressure values were utilized to calculate mean arterial pressure 
(MAP) and glucose and insulin values were utilized to calculate homeostasis model 
assessment (HOMA).  Then, waist circumference, MAP, HOMA, HDL-cholesterol, and 
triglycerides were all regressed onto age, race, and sex.  The age utilized was the age in 
months at examination.  Gender and race/ethnicity were obtained via the demographic 
questionnaire.  Race/ethnicity is categorized into the following groups: Non-Hispanic 
White, Non-Hispanic Black, Mexican American, Other Hispanic, or Other Race – 




because higher HDL is beneficial for disease risk.  Finally, the standardized scores were 
summed to create the continuous metabolic syndrome score (33).      
Sample Size 
Adolescents ages 12-19 years (n=6,861) included in the NHANES 2001-2006 
datasets were considered for this study.  Adolescents were excluded from the study if 
they were pregnant (n=145), if they did not have reliable dietary recall data (n=302), if 
they did not have a serum cotinine value (n=658), if they reported smoking in the past 5 
days (n=804), and if their value was missing for self-reported smoking in the past 5 days 
(n=611).  Smokers were also removed from the dataset using race/age-specific cotinine 
ng/mL cut point values (non-Hispanic white males = 8.78; non-Hispanic black males = 
6.01; Mexican-American males = 1.18; non-Hispanic white females = 2.95; non-Hispanic 
black females = 2.81; Mexican American females = 0.66; other ethnicities = 2.99) 
established by Benowitz and colleagues (n = 1,783) (34).  Of the 4,663 adolescents not 
excluded by the criteria already listed, additional adolescents were removed if they were 
missing cholesterol, blood pressure, or 2-year fasting subsample weight (total cholesterol 
= 20, LDL = 2,503, triglyceride = 2,442, HDL-cholesterol = 20, blood pressure = 671, 2-
year fasting subsample weight = 242).  After these exclusions, 1,858 adolescents 
remained in the sample.   
Statistical Analysis 
Statistical analyses for this study were conducted using STATA.  Two-year 
fasting survey weights were utilized to calculate a 6-year survey weight according to 
NHANES protocol (35).  The svy function was utilized for analyses.  This command 




used to input the 6-year survey weight, masked variance pseudo primary sampling unit, 
and masked variance pseudo stratum.   
All variables were examined to determine if they were normally distributed.  If 
they were not normally distributed, variables were transformed.  If a variable’s 
distribution remained non-normal after transformation, a dichotomous or categorical 
variable was created and utilized for analyses.  Several variables were not normally 
distributed upon examination.  Possible values for PIR category included poor (PIR < 1), 
near poor (1<PIR<2), and not poor (PIR>2).  A large proportion of adolescents had 
cotinine values at or below the limit of detection.  Therefore, for this study, analyses 
utilized a dichotomous variable for cotinine where those with cotinine <0.05 ng/mL had a 
value of 0 and those with cotinine >0.05 ng/mL having a value of 1.   
Analyses did not control for age, gender, or race/ethnicity as these were all 
utilized to calculate the continuous metabolic syndrome score; however, analyses did 
include Poverty Income Ratio (PIR) category as a covariate to control for potential 
confounding due to socioeconomic status.  PIR is based on income determined by the 
Department of Health and Human Services guidelines in the Federal Register to represent 
poverty.  It accounts for family size, location, and year (36).    
To examine the potential interaction between ETS exposure and dietary patterns 
or intake as they relate to metabolic syndrome, general linear models and ordinal 
regressions with interaction terms were run using the svy command (37).  Analyses were 
first run with ETS exposure, the dietary variable of interest, the interaction term, and the 
outcome.  Potential confounding variables (i.e. PIR category and calories) were added 




5.3 RESULTS  
Study Sample Characteristics 
Descriptive statistics for the study sample are presented in Table 5.1.  The average 
age of the adolescents was 15.5 years (SE = 0.9 months).  Roughly half (50.4 percent) of 
the sample was male and half (49.7 percent) was female.  More than half (61.5 percent) 
of the sample had a PIR two times the poverty level and only 16.9 percent had a PIR at or 
below poverty level.  Just under half of the study population (49.1 percent) had cotinine 
>0.05 ng/mL.  Diet quality score and dietary intake score averages and standard errors are 
also presented in Table 5.1.  Less than 10 percent of the study population met the AI for 
fiber and the RDA for vitamin E.  Just over one quarter of the study population (26.0 
percent) reported taking a dietary supplement in the past 30 days.  The average 
continuous metabolic syndrome score was -0.1 (SE = 0.1). 
General Linear Models 
Appendix 5.A. presents results from general linear models testing the relationship 
between dietary intake and metabolic syndrome score.  Log of fiber intake and meeting 
the RDA for folate were the only variables statistically significantly related to lower 
metabolic syndrome score.  Results from the general linear models examining potential 
interactions between the effects of diet intake and quality variables and cotinine 
concentration on continuous metabolic syndrome score are presented in Tables 5.2 and 
5.3.  DASH diet score, AHEI 2010 score, meeting AI for fiber intake, and meeting the 
RDA for vitamin C, vitamin E, and RAE intake were not statistically significantly related 
to metabolic syndrome score and the interaction terms in these models were not 




Meeting the RDA for DFE was statistically significantly associated with lower 
metabolic syndrome score (β = -0.9, 95% CI -1.5, -0.4) even after adjustment for total 
energy intake and PIR category  (β = -0.9, 95% CI -1.4, -0.3).  However, the interaction 
term in these models was not statistically significant (β = 0.7, 95% CI -0.2, 1.6) even 
after adjustment for total energy intake and PIR category (β = 0.7, 95% CI -0.2, 1.6).   
Because 26 percent of the population reported using dietary supplements in the 
past 30 days, analyses were re-run controlling for dietary supplement use.  Interaction 
terms in these models were not statistically significant. 
5.4 DISCUSSION  
This study sought to examine whether measures of diet quality and dietary intake 
mitigate the harmful effects of ETS exposure on metabolic syndrome in adolescents.  
Previous findings in Chapter 4 indicated that part of the relationship between ETS 
exposure and increased metabolic syndrome score was mediated by biomarkers of folate, 
trans-β-carotene, and ascorbic acid.  Therefore, it was hypothesized that dietary intake 
may modify the relationship between ETS exposure and metabolic syndrome score.  
However, analyses did not demonstrate an interaction between ETS exposure and aHEI 
score, DASH diet score, or measures of dietary intake in their effect on metabolic 
syndrome.     
This study has many strengths such as the nationally representative sample, the 
standardized study procedures utilized in NHANES, and the use of cotinine as an 
objective measure of ETS exposure.  This study included examination of adequacy of 
intake of individual micronutrients using RDAs in addition to summary scores of diet 




for individual micronutrients were met on that given day could be chance findings, the 
diet quality scores are likely to capture diet quality as a whole since they take into 
account multiple components of dietary intake.   
Study limitations include the cross-sectional nature of the study design which 
excludes the ability to assess temporality and the use of data from just one 24-hour 
dietary recall. 
It is important to consider the relationship between dietary intake and nutrient 
biomarkers.  Dietary intake and nutrient biomarkers are not perfectly correlated.  A 
review of studies of folate intake and biomarkers of folate in the blood found moderate 
correlations between folate intake as assessed by 24-hour dietary recall and biomarkers of 
folate (ranging from 0.18 to 0.55) when accounting for supplement use (38).  A meta-
analysis of studies of dietary intake in adults found that vitamin C intake assessed by 
dietary recall was positively correlated with plasma vitamin C concentration (r = 0.46) 
and this included studies which accounted for supplement use (39).  In one study of 
adults, the correlation between 24-hour dietary recall, energy- and serum cholesterol-
adjusted alpha-tocopherol intake and serum alpha-tocopherol ranged from 0.50 to 0.61 
and for carotene ranged from 0.47 to 0.55 (40).   
The authors are not aware of systematic evaluations of the correlation between 
dietary intake and nutrient biomarkers in the adolescent population.  Appendix 5.B. 
presents the correlations between dietary intake and nutrient biomarkers in the adolescent 
population examined in this study.  These analyses were performed in STATA using the 
CORR_SVY to adjust for survey strata, PSUs, and weights.  All of the dietary intake 




examined at the 0.01 level.  Analyses were re-run with the dietary intake variable 
examined per 1,000 kcals, and correlations remained statistically significant.  Correlation 
coefficients were moderate and ranged from 0.2-0.4.     
Other studies have not examined these exact interactions, but a recent study 
examined the impact of meeting the adequate intake for tocopherol on the impact of ETS 
exposure on lung cancer risk and did find that it had a protective effect (41).   
Some older studies demonstrated that antioxidant supplementation can reduce 
oxidative stress and even mitigate some of the harmful effects of ETS exposure (42-44).  
However, reviews of the literature have demonstrated that antioxidant supplements do not 
offer the benefits originally hoped for – instead, they either have no impact or can 
potentially increase mortality (45).  The authors of the review hypothesized that the 
reason for this potential harmful effect is that there is a delicate balance that may vary 
from person to person between antioxidants and free radicals and that some free radicals 
are needed in the body (45).  Another theory is that endogenous antioxidants have more 
of an impact on chronic disease risk than dietary antioxidants (45).  If there is, in fact, a 
narrow range of quantity of dietary antioxidant intake that would be able to affect the 
relationship between ETS exposure and chronic disease risk, it is possible that the intake 
of antioxidants amongst this study sample was not within that range.   
Another potential explanation for the discrepancy between other study findings 
and findings from this study is the cross sectional nature of the NHANES.  The 24-hour 
dietary recall data from this study was obtained at the same time point as the ETS 
exposure variable and the variables used to calculate the metabolic syndrome score.  To 




an ideal study would be longitudinal in nature.  Researchers would need to take baseline 
measurements of chronic disease risk, assess (and potentially manipulate) diet 
quality/intake and ETS exposure multiple times, and include follow-up measurement of 
chronic disease risk.  A longitudinal design would not only establish temporality but 
could also allow time for the effect of the diet quality/intake to become significant 
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Table 5.1 Descriptive characteristics of adolescents from NHANES 2001-2006 adjusted for study 
design 
  
Age (months), x̄ (SE) 186.4 (0.9) 
Sex, % (SE)  
Male 50.4 (0.0) 
Female 49.7 (0.0) 
Race/Ethnicity, % (SE)  
Mexican American 12.0 (0.0) 
Other Hispanic 3.7 (0.0) 
Non-Hispanic White 62.6 (0.0) 
Non-Hispanic Black 14.9 (0.0) 
Other race- including multi-racial 6.7 (0.0) 
Poverty Income Ratio category, % (SE)  
PIR greater than 2 (2*poverty level) 61.5 (0.0) 
PIR greater than poverty level (1) but less than or 
equal to 2 (2*poverty level) 
21.6 (0.0) 
PIR 0 to 1 at or below poverty level  16.8 (0.0) 
Cotinine (ng/mL), % (SE)  
<0.05 ng/mL 50.9 (0.0) 
>0.05 ng/mL 49.1 (0.0) 
DASH diet adherence score, x̄ (SE) 1.2 (0.0) 
AHEI 2010 score, x̄ (SE) 25.5 (0.4) 
Met Adequate Intake for Fiber, % (SE) 4.8 (0.0) 
Met RDA for Vitamin C, % (SE) 44.2 (0.0) 
Met RDA for Dietary Folate Equivalents, % (SE) 66.5 (0.0) 
Met RDA for Retinol Activity Equivalents, % (SE) 26.7 (0.0) 
Met RDA for Vitamin E, % (SE) 6.3 (0.0) 
Took dietary supplement in past 30 days, % (SE) 26.0 (0.0) 






Table 5.2. Interaction between effects of ETS exposure and DASH diet/AHEI 2010 score 
adherence on continuous metabolic syndrome score 
 
 
DASH adherence AHEI 2010 
  β 95% CI β 95% CI 
Unadjusted models (n=1,765)       
Cotinine >0.05 ng/mL
1
 0.2 -0.3 0.7 -0.4 -1.4 0.5 
DASH score 0.1 -0.1 0.2    
AHEI 2010 Score    -0.0 -0.0 0.0 
Interaction  0.1 -0.2 0.5 0.0 -0.0 0.1 
       
Adjusted models
2
 (n=1,693)       
Cotinine >0.05 ng/mL
1
 0.2 -0.4 0.7 -0.5 -1.5 0.5 
DASH score 0.1 -0.1 0.2    
AHEI 2010 Score    -0.0 -0.1 0.0 




 Reference group has no detectable cotinine or cotinine below 0.05 ng/mL  
2





Table 5.3. Interaction between effects of ETS exposure and nutrient intake on continuous metabolic syndrome  score  
  
Fiber Folate Vitamin C Vitamin A Vitamin E 
  
β 95% CI β 95% CI β 95% CI β 95% CI β 95% CI 





0.3* 0.0 0.6 -0.2 -0.9 0.5 0.2 -0.2 0.7 0.3 -0.1 0.6 0.3* 0.1 0.6 
Met AI? Fiber -0.2 -1.0 0.6 
            
Met RDA? 
 
               
 
Folate 
   
-0.9** -1.5 -0.4 
         
 
Vitamin C 
      
0.0 -0.4 0.4 
      
 
Vitamin A 
         
-0.1 -0.5 0.4 
   
 
Vitamin E 
            
0.0 -0.9 0.8 
Interaction term
3
 0.5 -0.8 1.8 0.7 -0.2 1.6 0.2 -0.5 0.8 0.1 -0.8 1.1 -0.3 -2.3 1.7 
  
               
Adjusted models
2





0.3 -0.0 0.5 -0.3 -1.0 0.4 0.3 -0.2 0.7 0.3 -0.1 0.6 0.3* 0.0 0.6 
Met AI? Fiber 0.0 -0.9 0.9 
            
Met RDA? 
 
               
 
Folate 
   
-0.9** -1.4 -0.3 
         
 
Vitamin C 
      
0.1 -0.4 0.6 
      
 
Vitamin A 
         
0.1 -0.4 0.6 
   
 
Vitamin E 
            
0.2 -0.7 1.1 
Interaction term
3




 Reference group has no detectable cotinine or cotinine below 0.05 ng/mL  
2
 Models adjusted for total caloric intake and Poverty Income Ratio 
3 




Appendix 5.A. Dietary intake and continuous metabolic syndrome score estimated using general linear models
1 
 Unadjusted model Adjusted model
2
 
Independent Variable n β 95% Confidence 
Interval 
n β 95% Confidence 
Interval 
DASH 1765 0.1 -0.0 0.3 1693 0.1 -0.1 0.3 
AHEI 2010
3 
1765 -0.0 -0.5 0.6 1693 -0.0 -0.0 0.0 
Percent kcal from saturated fat 1765 -4.4 -8.9 0.1 1693 -3.8 -8.5 0.8 
Log fiber intake
3 
1765 -0.4** -0.7 -0.1 1693 -0.4* -0.7 -0.0 
Log vitamin C intake
3 
1760 -0.0 -0.2 0.1 1688 -0.0 -0.2 0.2 
Log folate intake
3 
1765 -0.4* -0.7 -0.1 1693 -0.3* -0.7 -0.0 
Log beta carot
3 
1759 -0.1 -0.2 0.1 1687 -0.0 -0.2 0.1 
Log vitamin E
3 
1765 -0.2 -0.5 0.1 1693 -0.0 -0.5 0.4 
Met folate RDA
3 
1765 -0.6** -0.9 -0.2 1693 -0.5** -0.9 -0.2 
Met fiber RDA
3 
1765 -0.1 -0.7 0.6 1693 -0.2 -0.6 0.9 
Met vitamin C RDA
3 
1765 0.1 -0.2 0.4 1693 0.1 -0.2 0.5 
Met vitamin A RDA
3 
1765 -0.1 -0.4 0.3 1693 0.1 -0.2 0.4 
Met vitamin E RDA
3 




The outcome variable for all of the models was continuous metabolic syndrome score. 
2 
All adjusted models included PIR category and whether or not the participant reported taking supplements as covariates. 
3 




Appendix 5.B. Correlations between dietary intake and biomarkers in adolescent sample* 
Dietary intake variable Biomarker n Correlation 
coefficient 
P-value 
Log of dietary folate equivalents Serum folate 1779 0.2 0.0 
Log of dietary folate equivalents RBC folate 1774 0.2 0.0 
Log of vitamin C intake Ascorbic acid 1136 0.4 0.0 
Log of RAE Log of trans-β-carotene 1766 0.2 0.0 
Log of dietary folate equivalents per 1,000 kcal Serum folate 1779 0.3 0.0 
Log of dietary folate equivalents per 1,000 kcal RBC folate 1774 0.2 0.0 
Log of vitamin C intake per 1,000 kcal Ascorbic acid 1136 0.4 0.0 
Log of RAE per 1,000 kcal Log of trans-β-carotene 1776 0.2 0.0 






While smoking has declined over recent decades and anti-smoking campaigns and 
legislation have been put into place, smoking is still a problem in the United States.  
Smoking is a direct contributor to a plethora of health problems including cardiovascular 
disease, diabetes, and metabolic syndrome.  These same diseases are impacted by 
exposure to ETS.  Adolescents are particularly susceptible to smoking and ETS due to 
increasing importance of peer influence, incomplete/developing cognitive ability to think 
abstractly, and the desire to establish autonomy.  While adolescent smoking has declined, 
it is still prevalent in the United States.  The same characteristics of adolescence that 
make adolescents vulnerable to smoking also put adolescents at risk for poor dietary 
intake.  Adolescents in the United States do not consume recommended amounts of fruits 
and vegetables, and vegetable intake has declined in recent years.  Poor diet and diet 
quality also contribute to chronic disease risk.  Furthermore, both diet and ETS exposure 
affect nutrient biomarkers which are also related to chronic disease risk.  Because ETS 
exposure and poor diet quality can both have a negative impact on chronic disease risk 
and are both health behaviors of particular concern in adolescence, it is important to 
study these relationships together. 
The goal of this body of work was to expand understanding of the relationship 
between ETS exposure, dietary quality and intake, nutrient biomarkers, and chronic 
disease risk in adolescents.  This research was designed to identify potential high risk 




understanding of how ETS impacts chronic disease risk, and determine whether diet can 
affect the relationship between ETS exposure and chronic disease risk.   
Paper 1 describes analyses that were conducted to examine whether dietary 
quality and intake differed by ETS-exposure in adolescents to understand whether ETS 
exposure and poor diet quality coexist in the adolescent population.  This important 
question could identify a higher risk group of adolescents with multiple exposures known 
to increase risk of chronic disease.  The next paper aimed to determine which chronic 
disease measures were impacted by ETS and explore whether nutrient biomarkers are 
mediators in this relationship.  Understanding how ETS impacts chronic disease is 
essential for identifying appropriate interventions to mitigate this risk.  In the final paper, 
potential interactions between ETS exposure and dietary quality/intake in their 
relationship with chronic disease risk were tested.  The following sections provide a 
discussion of the study findings, strengths, limitations, implications for future research, 
and broader public health impact.   
6.1 SUMMARY OF MAJOR FINDINGS  
 The results of the first paper indicate that ETS exposure was associated with 
poorer diet quality and intake in adolescents.  ETS exposure was associated with lower 
DASH adherence, AHEI score, β-carotene, vitamin C, and fiber intake, and greater intake 
of saturated fat in adolescents – all indicative of poorer diet quality.  Furthermore, the 
fact that these associations were statistically significant with or without adjustment for 
confounding variables and when characterizing ETS-exposure using self-reported ETS 
exposure and cotinine concentration strengthens the confidence in these findings.  




from this study regarding ETS exposure and micronutrient consumption are consistent 
with the adult literature.  This was the first study to examine differences in diet quality as 
measured by AHEI 2010 and DASH scores by ETS exposure.   
ETS exposure increases risk for chronic diseases.  If ETS-exposed adolescents are 
also consuming lower amounts of micronutrients that are protective against chronic 
disease, this could mean that they are at an even greater risk of development of chronic 
disease.  The combination of ETS exposure and poor diet quality, both with respect to 
micronutrient consumption and overall diet quality, indicates that these adolescents 
should be targeted for interventions to address these exposures. 
 The second paper examined relationships between ETS exposure and chronic 
disease, nutrient biomarker concentration and chronic disease, and potential mediating 
relationships.  Self-reported ETS-exposure was not statistically significantly related to 
any of the measures of chronic disease or chronic disease risk.  This is not consistent with 
some studies available in the literature.  Under-reporting of ETS exposure could mask a 
legitimate relationship, so analyses were also conducted with cotinine concentration – a 
more objective measure of ETS exposure.  While not related to hypertension or diabetes, 
cotinine concentration over 0.05 ng/mL was statistically significantly related to 
continuous metabolic syndrome score.  This is consistent with findings from studies that 
have examined the relationship between ETS exposure and dichotomously characterized 
metabolic syndrome.  Given that the prevalence of hypertension and diabetes is low in 
the adolescent population, but the metabolic syndrome score is a continuous measure of 
disease risk, it would be more difficult to detect a relationship between ETS-exposure and 




were each associated with lower metabolic syndrome score.  These nutrient biomarkers 
were also found to partially mediate the relationship between cotinine concentration and 
metabolic syndrome score.  This mediation relationship has not been studied previously. 
 ETS exposure causes oxidative stress, platelet aggregation, endothelial 
dysfunction, and inflammation (1).  As mentioned in Chapter 2, β-carotene is needed for 
epithelial cell differentiation, signaling, and communication – all of which can impact 
chronic disease risk (2).  β-carotene is also an antioxidant.  It is possible that the oxidative 
stress, platelet aggregation, inflammation, and endothelial dysfunction caused by ETS (1, 
3) is so great that it stresses the body, resulting in lower concentrations of antioxidants in 
the blood and increased risk of chronic disease.     
 Finally, the third paper aimed to test the hypothesis that dietary intake/quality 
modifies the relationship between ETS exposure and chronic disease risk.  No 
statistically significant interactions were identified between DASH diet score, aHEI 
score, and intake of retinol activity equivalents (RAEs – the unit of measure for vitamin 
A requirements that adjusts for the differences in bioavailability of various forms of 
vitamin A), vitamin E, vitamin C, DFEs, or fiber.  This is the first study which examined 
the potential interaction between ETS exposure and dietary intake/quality in the 
relationship with chronic disease risk in adolescents.  While older studies in adults 
initially found a protective effect of antioxidant supplements against the negative impact 
of ETS on chronic disease risk, more recent evaluations of the overall impact of 
antioxidant supplementation on chronic disease risk has demonstrated no protective effect 




ETS-exposed individuals with higher diet quality scores and greater intake of vitamins A, 
C, E, folate, and fiber in this sample to observe a moderating relationship.      
6.2 STRENGTHS AND LIMITATIONS 
All research has both strengths and limitations.  This study utilized data from the 
National Health and Nutrition Examination Survey (NHANES) which is a large, 
nationally representative survey with strict data protocols and quality control checks 
integrated throughout.  This is a major strength over previous studies of similar topics 
which have smaller, less diverse samples. 
Examination of the relationship between ETS, diet quality, nutrient biomarkers, 
and chronic disease risk in an adolescent population is also a strength of this study as 
most studies examine these relationships in adults.  Adolescents have greater exposure to 
ETS than adults.  Furthermore, while chronic disease starts to develop in childhood, 
because fewer adolescents have heart disease, diabetes, and metabolic syndrome than 
adults, this life stage is an important one for prevention. 
The elimination of smokers from the dataset is both a strength and a weakness.  
The mechanism by which smokers were eliminated is a strength over previous studies as 
both self-report and previously established cutoff values were utilized to remove 
smokers.  Taking smokers out of the sample also allowed analyses to pinpoint the impact 
of environmental tobacco smoke and not smoking.  However, because smokers are likely 
to have the highest ETS exposure levels, it could also have reduced the power to detect 
meaningful differences or dampened the magnitude of the effects observed.   
Other studies examining chronic disease risk in children often characterize 




not very high in adolescents.  Because the variables used to diagnose metabolic syndrome 
are continuous, a continuous metabolic syndrome score was constructed.  Utilizing a 
continuous metabolic syndrome score is a unique strength of this study.  This allows pre-
clinical elevations in blood pressure, fasting plasma glucose, triglycerides, waist 
circumference, and reductions in high density lipoprotein (HDL) cholesterol to be 
detected and reduces the sample size required to detect relationships. 
The main limitation of this study is that the data are cross-sectional and were not 
designed for evaluating this type of longitudinal relationship.  Temporality is one of the 
criteria for establishing causal relationships; therefore, the findings from this study only 
suggest plausible relationships which need to be investigated further in a longitudinal or 
experimental setting.  This is especially true for the mediation analyses.  Maxwell and 
Cole demonstrated that using cross-sectional data to test for mediation results in biased 
estimates even if the mediation relationship is already complete in both autoregressive 
and random effects change models (5). 
Another limitation of this study is that the dietary intake variables were based on 
one 24-hour dietary recall.  Though the use of the Food Frequency Questionnaire (FFQ) 
data was considered, the NHANES FFQ does not record portion size; therefore, it would 
not provide an accurate portrait of individuals’ food consumption.  The 24-hour dietary 
recall only characterizes the previous day of intake of individuals in the study.  One day 
does not accurately represent any one individual’s usual dietary intake.  The 24-hour 
dietary recall data is prone to recall bias; however, the threat of recall bias is reduced for 




Diagnosis of cardiovascular disease and/or diabetes is often associated with 
recommendations from clinicians for changes in diet; therefore, reverse causality is a 
distinct possibility.  However, given that the study population was adolescents, reverse 
causality is less likely than it would be in an adult population.  Another limitation of the 
study was the lack of confirmation of elevated fasting plasma glucose on a second day 
and high blood pressure on a second day to meet the requirements for diagnosis of 
diabetes and hypertension (6, 7).   
One criticism of the Sobel test is the assumption of a normal sampling distribution 
for ab when it ordinarily is asymmetrical (8).  However, the sampling distribution of ab is 
usually normal in large samples, so this is less of a concern in this study (9).   
Despite the limitations of this study, the research provides important 
contributions.  Novel findings include the discovery that ETS-exposed adolescents have 
poorer diet quality than their unexposed peers, that ETS-exposure is related to chronic 
disease risk in adolescents, and that the relationship between ETS-exposure and chronic 
disease risk may be partially mediated by nutrient biomarkers.  Not only does this work 
provide a greater understanding of the relationship between ETS exposure, diet quality 
and intake, nutrient biomarkers, and chronic disease risk in adolescents – it also lays the 
framework for future research and policies. 
6.3 IMPLICATIONS FOR RESEARCH AND POLICY 
Cardiovascular disease, diabetes, and metabolic syndrome are major public health 
issues in the United States.  In Chapter 2, a study was presented in which the prevalence 
of metabolic syndrome was reported to be 8.6 percent in adolescents (10).  This study 




data from 2001-2010 found metabolic syndrome prevalence to be 10.1 percent amongst 
adolescents (11).  Thus, the public health problem still exists and may be on the rise.     
Adolescence is an important time for health behavior interventions, especially for 
smoking and substance abuse-related behaviors and dietary intake.  As mentioned in 
Chapter 2, adolescence is a period when children are establishing their sense of self and 
autonomy from their parents and when peers become more influential.  The ability to 
think abstractly and understand longer term consequences of behavior is something that 
develops during adolescence and is not fully developed until adulthood; therefore, 
adolescents may not be able to ascribe possible negative health impacts to their own 
health behavior choices.  Adolescence is a period of feeling invincible – like nothing bad 
can happen; this aspect of this developmental life stage could make adolescents more 
prone to subjecting themselves to ETS exposure and eating unhealthy diets.   Finally, 
health behaviors have been demonstrated to track from adolescence to adulthood, so the 
formation of healthy behaviors in adolescence is critical. 
Because adolescents who are exposed to ETS also have poorer diet, it is likely 
that they are at an even greater risk for chronic disease because both poor diet quality and 
ETS exposure are risk factors for chronic disease.  The identification of this high risk 
population suggests that adolescents exposed to ETS may be in need of multiple 
interventions to decrease their disease risk – both to reduce ETS exposure and improve 
diet quality.   
Future research could determine why ETS exposure and poor diet quality and 
intake coexist; for example, is this due to familial, peer, or individual influences?  




poorer diet quality, it is possible that adolescents with parents who smoke have greater 
ETS exposure and poorer diets due to the food environment (both food choices and foods 
that are available) their parents have created.  However, because adolescence is a time 
when children begin to focus more on their peers, peer influences should also be 
considered.  It is possible that adolescents gain exposure to ETS through spending time 
with peers who smoke and that those peers guide their food choices as well.  Identifying 
the root cause of this problem could be key for finding appropriate interventions to target 
adolescents. 
Chapter 3 demonstrated that over 30 percent of adolescents who reported no ETS 
exposure in the home had cotinine concentrations >0.05 ng/mL.  NHANES should 
continue to measure cotinine amongst adolescents because participants may not be 
forthcoming about their exposure due to the stigma associated with smoking. 
Furthermore, self-reported exposure questions provide a context for where the exposure 
occurred. 
The relationship between active smoking and chronic disease has been examined, 
but fewer studies have examined the relationship between ETS exposure and chronic 
disease, especially in the adolescent population.  ETS exposure has been demonstrated to 
be related to dichotomous metabolic syndrome score; however, this study demonstrated 
that it is also positively correlated with a continuous metabolic syndrome score, 
reinforcing the finding that the effects of secondhand smoke on chronic disease can be 
observed as early as adolescence. This clearly provides further support for tobacco 
regulations which would limit exposure to adolescents and children; however, it also 




disease risk.  This finding could be utilized to motivate parents to quit smoking.  It also 
has policy implications.  While landlords are allowed to ban smoking from their 
properties, it is not a requirement.  Future legislation could incorporate regulations 
regarding smoking in rental housing – for example, buildings with over a certain number 
of units could not allow smoking.   
These analyses were conducted with data from 2001-2006.  Newer NHANES data 
is available and these analyses could be repeated with more recent data to see if these 
relationships have continued or changed over time.  Smoking prevalence has decreased in 
recent years; however, vegetable consumption has not improved. 
To better understand the long-term impact of ETS exposure on chronic disease 
risk, a longitudinal study is warranted.  A longitudinal study would increase support for 
the finding that nutrient biomarkers partially mediate the relationship between ETS 
exposure and metabolic syndrome score.  While this study provides evidence that this 
relationship may exist, in order to prove causality, temporality is a critical missing link.  
If a study first examined ETS exposure, then later measured nutrient biomarkers, and 
finally later assessed metabolic syndrome risk and still found evidence of mediation, this 
would suggest that one of the mechanisms by which ETS impacts chronic disease risk is 
through creating an imbalance between nutrient concentration and biological processes 
requiring those nutrients.    
The lack of statistically significant interaction in the third paper does not 
necessarily mean that dietary intake/quality do not modify the relationship between ETS 
exposure and metabolic syndrome risk.  Because dietary intake of micronutrients and 




sample who had higher intake of the micronutrients being examined did not, in fact, have 
higher nutrient biomarker concentration.   
These papers made new contributions to the literature with respect to ETS 
exposure, nutrient biomarkers, dietary intake/quality, and chronic disease risk.  This work 
has identified a sub-group of adolescents who are potentially at higher risk for chronic 
disease due to multiple risk factors; determined that the negative effects of ETS exposure 
on chronic disease risk are evident as early as adolescence; provided support for the 
theory that one of the mechanisms by which ETS exposure affects chronic disease risk is 
through changes in nutrient biomarkers and biological processes that depend on those 
nutrients; and initiated investigation into the potential for dietary intake to impact the 
relationship between ETS and chronic disease risk.  These findings support strict 
regulation of ETS exposure to adolescents and children, addition of dietary intervention 
to interventions targeting ETS-exposed adolescents, and further investigation to 
determine whether or not increasing micronutrient intake, via diet or supplement use, can 
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